|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
DE2023169C2
(de)
|
1970-05-12 |
1982-07-22 |
Hannes 8100 Garmisch-Partenkirchen Marker |
Sicherheitsskibindung
|
|
JPS5745009Y2
(enExample)
|
1979-01-31 |
1982-10-04 |
|
|
|
JPS5846044Y2
(ja)
|
1979-06-19 |
1983-10-20 |
三洋電機株式会社 |
ポンプの梱包装置
|
|
JPS5760007Y2
(enExample)
|
1980-08-08 |
1982-12-21 |
|
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
CH652145A5
(de)
|
1982-01-22 |
1985-10-31 |
Sandoz Ag |
Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
|
|
JPS58154591A
(ja)
|
1982-03-09 |
1983-09-14 |
Tadao Nakaya |
リン脂質類似モノマ−の製造法
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
|
US4609707A
(en)
|
1983-11-10 |
1986-09-02 |
Genetic Systems Corporation |
Synthesis of polymers containing integral antibodies
|
|
US4634666A
(en)
|
1984-01-06 |
1987-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human-murine hybridoma fusion partner
|
|
US4754065A
(en)
|
1984-12-18 |
1988-06-28 |
Cetus Corporation |
Precursor to nucleic acid probe
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
MX9203440A
(es)
|
1985-04-12 |
1992-07-01 |
Genetics Inst |
Proteinas procoagulantes novedosas.
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
US5250421A
(en)
|
1986-01-03 |
1993-10-05 |
Genetics Institute, Inc. |
Method for producing factor VIII:C-type proteins
|
|
US5198349A
(en)
|
1986-01-03 |
1993-03-30 |
Genetics Institute, Inc. |
Method for producing factor VIII:C and analogs
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
EP0282610B1
(de)
|
1987-03-16 |
1990-06-06 |
Dr.Ing.h.c. F. Porsche Aktiengesellschaft |
Vorderachsgetriebe für Allradfahrzeuge
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
JPH0387173A
(ja)
|
1987-09-10 |
1991-04-11 |
Teijin Ltd |
ヒト活性化天然型ファクター８ｃの製造方法及びそれに用いる形質転換体
|
|
NZ226414A
(en)
|
1987-10-02 |
1992-07-28 |
Genentech Inc |
Cd4 peptide adhesion variants and their preparation and use
|
|
US5336603A
(en)
|
1987-10-02 |
1994-08-09 |
Genentech, Inc. |
CD4 adheson variants
|
|
US5283187A
(en)
|
1987-11-17 |
1994-02-01 |
Brown University Research Foundation |
Cell culture-containing tubular capsule produced by co-extrusion
|
|
US4892538A
(en)
|
1987-11-17 |
1990-01-09 |
Brown University Research Foundation |
In vivo delivery of neurotransmitters by implanted, encapsulated cells
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
US5252713A
(en)
|
1988-09-23 |
1993-10-12 |
Neorx Corporation |
Polymeric carriers for non-covalent drug conjugation
|
|
US5162218A
(en)
|
1988-11-18 |
1992-11-10 |
The Regents Of The University Of California |
Conjugated polypeptides and methods for their preparation
|
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP0832980B1
(en)
|
1989-01-23 |
2002-06-19 |
Chiron Corporation |
Recombinant therapies for infection and hyperproliferative disorders
|
|
DK0737750T3
(da)
|
1989-03-21 |
2003-09-01 |
Vical Inc |
Ekspression af exogene polynucleotidsekvenser i vertebrater
|
|
US6673776B1
(en)
|
1989-03-21 |
2004-01-06 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
EP1001032A3
(en)
|
1989-08-18 |
2005-02-23 |
Chiron Corporation |
Recombinant retroviruses delivering vector constructs to target cells
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
ZA911974B
(en)
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
WO1991017773A2
(de)
|
1990-05-18 |
1991-11-28 |
Boehringer Ingelheim International Gmbh |
Neue protein-polykation-konjugate
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
EP0584082B1
(en)
|
1991-01-31 |
2000-05-31 |
Cor Therapeutics, Inc. |
Domains of extracellular region of human platelet derived growth factor receptor polypeptides
|
|
US5278299A
(en)
|
1991-03-18 |
1994-01-11 |
Scripps Clinic And Research Foundation |
Method and composition for synthesizing sialylated glycosyl compounds
|
|
DE4110409C2
(de)
|
1991-03-29 |
1999-05-27 |
Boehringer Ingelheim Int |
Neue Protein-Polykation-Konjugate
|
|
US5325525A
(en)
|
1991-04-04 |
1994-06-28 |
Hewlett-Packard Company |
Method of automatically controlling the allocation of resources of a parallel processor computer system by calculating a minimum execution time of a task and scheduling subtasks against resources to execute the task in the minimum time
|
|
US5858657A
(en)
|
1992-05-15 |
1999-01-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5871907A
(en)
|
1991-05-15 |
1999-02-16 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
AU666485B2
(en)
|
1991-07-05 |
1996-02-15 |
Biocompatibles Uk Limited |
Polymeric surface coatings
|
|
ATE237694T1
(de)
|
1991-08-20 |
2003-05-15 |
Us Gov Health & Human Serv |
Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
WO1993010260A1
(en)
|
1991-11-21 |
1993-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases
|
|
US5817310A
(en)
|
1991-12-02 |
1998-10-06 |
Cor Therapeutics, Inc. |
Inhibitory immunoglobulin polypeptides to human PDGF beta receptor
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
JPH07503132A
(ja)
|
1991-12-17 |
1995-04-06 |
ジェンファーム インターナショナル，インコーポレイティド |
異種抗体を産生することができるトランスジェニック非ヒト動物
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
EP0646178A1
(en)
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
expression cassette with regularoty regions functional in the mammmlian host
|
|
EP0650370A4
(en)
|
1992-06-08 |
1995-11-22 |
Univ California |
METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
|
|
EP0644946A4
(en)
|
1992-06-10 |
1997-03-12 |
Us Health |
VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM.
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
ATE198277T1
(de)
|
1992-10-02 |
2001-01-15 |
Genetics Inst |
Zusammensetzung, welche den koagulationsfaktor viii beinhaltet; verfahren zu deren herstellung und die benutzung eines oberflächenaktiven stoffes als stabilisator
|
|
EP0673431A1
(en)
|
1992-12-03 |
1995-09-27 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
|
ATE199392T1
(de)
|
1992-12-04 |
2001-03-15 |
Medical Res Council |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
GB9301701D0
(en)
|
1993-01-28 |
1993-03-17 |
Biocompatibles Ltd |
New zwitterionic materials
|
|
GB9301702D0
(en)
|
1993-01-28 |
1993-03-17 |
Biocompatibles Ltd |
New materials
|
|
JP3734262B2
(ja)
|
1993-03-25 |
2006-01-11 |
メルク エンド カンパニー インコーポレーテッド |
血管内皮細胞増殖因子阻害剤
|
|
AU6818094A
(en)
|
1993-04-22 |
1994-11-08 |
Depotech Corporation |
Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
|
|
EP0705344B8
(en)
|
1993-06-24 |
2006-05-10 |
Advec Inc. |
Adenovirus vectors for gene therapy
|
|
WO1995007994A2
(en)
|
1993-09-15 |
1995-03-23 |
Viagene, Inc. |
Recombinant alphavirus vectors
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
DE69435223D1
(de)
|
1993-10-25 |
2009-09-03 |
Canji Inc |
Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
HUT75162A
(en)
|
1993-11-16 |
1997-04-28 |
Depotech Corp |
Vesicles with controlled release of actives
|
|
GB9324033D0
(en)
|
1993-11-23 |
1994-01-12 |
Biocompatibles Ltd |
Ethylenically unsaturated compounds
|
|
US5914349A
(en)
|
1994-01-10 |
1999-06-22 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
|
|
US6436908B1
(en)
|
1995-05-30 |
2002-08-20 |
Duke University |
Use of exogenous β-adrenergic receptor and β-adrenergic receptor kinase gene constructs to enhance myocardial function
|
|
DE69535669T2
(de)
|
1994-05-09 |
2008-12-04 |
Oxford Biomedica (Uk) Ltd. |
Retrovirale vektoren mit verminderter rekombinationsrate
|
|
WO1996017072A2
(en)
|
1994-11-30 |
1996-06-06 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
|
US5681746A
(en)
|
1994-12-30 |
1997-10-28 |
Chiron Viagene, Inc. |
Retroviral delivery of full length factor VIII
|
|
US5763548A
(en)
|
1995-03-31 |
1998-06-09 |
Carnegie-Mellon University |
(Co)polymers and a novel polymerization process based on atom (or group) transfer radical polymerization
|
|
US6541580B1
(en)
|
1995-03-31 |
2003-04-01 |
Carnegie Mellon University |
Atom or group transfer radical polymerization
|
|
JPH09154588A
(ja)
|
1995-10-07 |
1997-06-17 |
Toagosei Co Ltd |
Ｖｅｇｆ結合性ポリペプチド
|
|
CN1202898A
(zh)
|
1995-10-16 |
1998-12-23 |
生物相容有限公司 |
磷化合物的氧化
|
|
GB9521234D0
(en)
|
1995-10-16 |
1995-12-20 |
Biocompatibles Ltd |
Synthesis of polymerisable phospho diesters
|
|
US5807937A
(en)
|
1995-11-15 |
1998-09-15 |
Carnegie Mellon University |
Processes based on atom (or group) transfer radical polymerization and novel (co) polymers having useful structures and properties
|
|
US5663425A
(en)
|
1996-01-26 |
1997-09-02 |
Lignotech Usa, Inc. |
Production of acid soluble humates
|
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
|
US5882644A
(en)
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
|
DE69739286D1
(de)
|
1996-05-06 |
2009-04-16 |
Oxford Biomedica Ltd |
Rekombinationsunfähige retrovirale vektoren
|
|
US6100071A
(en)
|
1996-05-07 |
2000-08-08 |
Genentech, Inc. |
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
|
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
|
US5789487A
(en)
|
1996-07-10 |
1998-08-04 |
Carnegie-Mellon University |
Preparation of novel homo- and copolymers using atom transfer radical polymerization
|
|
US6156884A
(en)
|
1996-08-05 |
2000-12-05 |
Prolinx, Inc. |
Bifunctional boronic compound complexing reagents and complexes
|
|
US5863551A
(en)
|
1996-10-16 |
1999-01-26 |
Organogel Canada Ltee |
Implantable polymer hydrogel for therapeutic uses
|
|
GB9621522D0
(en)
|
1996-10-16 |
1996-12-04 |
Biocompatibles Ltd |
Synthesis of phosphorus compounds
|
|
JPH10139832A
(ja)
|
1996-11-08 |
1998-05-26 |
Nof Corp |
共重合体およびグルコースセンサー
|
|
CA2281794A1
(en)
|
1997-02-21 |
1998-08-27 |
Genentech, Inc. |
Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
|
|
US7122636B1
(en)
|
1997-02-21 |
2006-10-17 |
Genentech, Inc. |
Antibody fragment-polymer conjugates and uses of same
|
|
US7125938B2
(en)
|
1997-03-11 |
2006-10-24 |
Carnegie Mellon University |
Atom or group transfer radical polymerization
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
CN104231078A
(zh)
|
1997-04-07 |
2014-12-24 |
基因技术股份有限公司 |
抗-血管内皮生长因子的抗体
|
|
US20070059302A1
(en)
|
1997-04-07 |
2007-03-15 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
US20020032315A1
(en)
|
1997-08-06 |
2002-03-14 |
Manuel Baca |
Anti-vegf antibodies
|
|
DE69829891T2
(de)
|
1997-04-07 |
2005-10-06 |
Genentech, Inc., South San Francisco |
Anti-VEGF Antikörper
|
|
US20150023951A1
(en)
|
1997-04-07 |
2015-01-22 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
JP3052923B2
(ja)
|
1997-05-30 |
2000-06-19 |
日本油脂株式会社 |
（メタ）アクリレート誘導体の製造方法
|
|
WO1999018792A1
(en)
|
1997-10-10 |
1999-04-22 |
Johns Hopkins University |
Gene delivery compositions and methods
|
|
AU752946B2
(en)
|
1997-10-16 |
2002-10-03 |
Avigenics, Inc. |
Vectors comprising a magnum-specific promoter for avian transgenesis
|
|
US8007798B2
(en)
|
1997-11-21 |
2011-08-30 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
US8088386B2
(en)
|
1998-03-20 |
2012-01-03 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
ATE333114T1
(de)
|
1998-01-30 |
2006-08-15 |
Albemarle Corp |
Maleimide enthaltende fotopolymerisierbare zusammensetzungen und verfahren zu deren verwendung
|
|
JP4162284B2
(ja)
|
1998-02-04 |
2008-10-08 |
日油株式会社 |
洗浄剤組成物
|
|
EP3056516A1
(en)
|
1998-02-20 |
2016-08-17 |
Genentech, Inc. |
Inhibitors of complement activation
|
|
US6121371A
(en)
|
1998-07-31 |
2000-09-19 |
Carnegie Mellon University |
Application of atom transfer radical polymerization to water-borne polymerization systems
|
|
US6153655A
(en)
|
1998-04-17 |
2000-11-28 |
Enzon, Inc. |
Terminally-branched polymeric linkers and polymeric conjugates containing the same
|
|
GB9812550D0
(en)
|
1998-06-11 |
1998-08-05 |
Aepact Ltd |
Tumour therapy and imaging
|
|
US6159942A
(en)
|
1998-06-19 |
2000-12-12 |
Bioenergy, Inc. |
Compositions for increasing energy in vivo
|
|
JP2002522063A
(ja)
|
1998-08-17 |
2002-07-23 |
アブジェニックス インコーポレイテッド |
増加した血清半減期を有する改変された分子の生成
|
|
JP4145403B2
(ja)
|
1998-09-29 |
2008-09-03 |
日油株式会社 |
免疫学的活性物質測定用高分子／酵素結合体
|
|
US6781030B1
(en)
|
1998-11-02 |
2004-08-24 |
Trustee Of Tufts College, Ballou Hall |
Methods for cloning mammals using telophase oocytes
|
|
AU1728800A
(en)
|
1998-11-18 |
2000-06-05 |
Genentech Inc. |
Antibody variants with higher binding affinity compared to parent antibodies
|
|
WO2000034337A1
(en)
|
1998-12-10 |
2000-06-15 |
Tsukuba Research Laboratory, Toagosei Co., Ltd. |
Humanized monoclonal antibodies against vascular endothelial cell growth factor
|
|
US6344050B1
(en)
|
1998-12-21 |
2002-02-05 |
Light Sciences Corporation |
Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
|
|
WO2000037658A2
(en)
|
1998-12-21 |
2000-06-29 |
Genencor International, Inc. |
Chemically modified enzymes with multiple charged variants
|
|
EP1579871A1
(en)
|
1998-12-22 |
2005-09-28 |
Genentech, Inc. |
Vascular endothelial cell growth factor antagonists and uses thereof
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
MY128897A
(en)
|
1999-02-05 |
2007-02-28 |
Samsung Electronics Co Ltd |
Image texture retrieving method and apparatus thereof
|
|
WO2000059968A1
(en)
|
1999-04-05 |
2000-10-12 |
The Research Foundation Of State University Of New York |
Graft, graft-block, block-graft, and star-shaped copolymers and methods of making them
|
|
EP1179541B1
(en)
|
1999-04-28 |
2004-06-16 |
Board Of Regents, The University Of Texas System |
Compositions and methods for cancer treatment by selectively inhibiting VEGF
|
|
FR2794459B1
(fr)
|
1999-05-19 |
2004-09-03 |
Atofina |
Polyalcoxyamines issues de nitroxydes beta-substitues
|
|
US7070959B1
(en)
|
1999-06-08 |
2006-07-04 |
Regeneron Pharmaceuticals, Inc. |
Modified chimeric polypeptides with improved pharmacokinetic properties
|
|
US7396664B2
(en)
|
1999-06-08 |
2008-07-08 |
Regeneron Pharmaceuticals, Inc. |
VEGF-binding fusion proteins and nucleic acids encoding the same
|
|
US6833349B2
(en)
|
1999-06-08 |
2004-12-21 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating inflammatory skin diseases
|
|
US7306799B2
(en)
|
1999-06-08 |
2007-12-11 |
Regeneron Pharmaceuticals, Inc. |
Use of VEGF inhibitors for treatment of eye disorders
|
|
CN101433715B
(zh)
|
1999-06-08 |
2013-04-17 |
里珍纳龙药品有限公司 |
具有改善的药物动力学特性的修饰嵌合多肽
|
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
|
GB9914650D0
(en)
|
1999-06-24 |
1999-08-25 |
Angyogene Pharmaceuticals Ltd |
Chimeric proteins mediating targeted apoptosis
|
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
ATE407697T1
(de)
|
1999-07-13 |
2008-09-15 |
Bolder Biotechnology Inc |
Erythropoietin immunglobulin fusionsproteine
|
|
US7049373B2
(en)
|
1999-08-06 |
2006-05-23 |
Carnegie Mellon University |
Process for preparation of graft polymers
|
|
JP4883515B2
(ja)
|
1999-09-08 |
2012-02-22 |
ポリセリックス リミテッド |
均一分子量ポリマー
|
|
JP4776843B2
(ja)
|
1999-10-01 |
2011-09-21 |
イムノゲン インコーポレーティッド |
免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
|
|
US6348554B1
(en)
|
1999-11-30 |
2002-02-19 |
Rohmax Additives Gmbh |
Method for preparation of a liquid polymer composition and use of this composition
|
|
GB9928956D0
(en)
|
1999-12-07 |
2000-02-02 |
Malik Navid |
Internally supported biomimetic coating systems
|
|
US7045314B2
(en)
|
2000-04-04 |
2006-05-16 |
Baxter International Inc. |
Method for the production of bacterial toxins
|
|
EP2792747A1
(en)
|
2000-06-23 |
2014-10-22 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
|
IL144815A
(en)
|
2000-08-11 |
2005-07-25 |
Sumitomo Chemical Co |
Process for producing carbonyl or hydroxy compound
|
|
US20020091082A1
(en)
|
2000-09-13 |
2002-07-11 |
Aiello Lloyd P. |
Methods of modulating symptoms of hypertension
|
|
EP1325046B1
(en)
|
2000-10-06 |
2007-06-27 |
Biocompatibles UK Limited |
Zwitterionic polymers
|
|
EP1337563B1
(en)
|
2000-10-06 |
2006-12-20 |
Carnegie-Mellon University |
Polymerization process for ionic monomers
|
|
AU2002211467A8
(en)
|
2000-10-06 |
2005-09-08 |
Univ Carnegie Mellon |
Preparation of nanocomposite structures by controlled polymerization
|
|
AU2001296670A1
(en)
|
2000-10-06 |
2002-04-15 |
Carnegie-Mellon University |
A catalyst system for controlled polymerization
|
|
US6979556B2
(en)
|
2000-12-14 |
2005-12-27 |
Genentech, Inc. |
Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
ATE470647T1
(de)
|
2001-04-06 |
2010-06-15 |
Univ Carnegie Mellon |
Verfahren zur herstellung von nanostrukturierten materialien
|
|
US20040010376A1
(en)
|
2001-04-17 |
2004-01-15 |
Peizhi Luo |
Generation and selection of protein library in silico
|
|
US7667004B2
(en)
|
2001-04-17 |
2010-02-23 |
Abmaxis, Inc. |
Humanized antibodies against vascular endothelial growth factor
|
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6780428B2
(en)
|
2001-06-08 |
2004-08-24 |
Labopharm, Inc. |
Unimolecular polymeric micelles with an ionizable inner core
|
|
AU2002368077B2
(en)
|
2001-07-12 |
2010-03-04 |
Jefferson Foote |
Super humanized antibodies
|
|
US20040253596A1
(en)
|
2001-08-27 |
2004-12-16 |
Michael Pawlak |
Bioanalytical recognition surface with optimized recognition element density
|
|
JP2003064132A
(ja)
|
2001-08-28 |
2003-03-05 |
Nof Corp |
重合体、製造方法および乳化・分散剤
|
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
|
WO2003020906A2
(en)
|
2001-08-31 |
2003-03-13 |
Abmaxis, Inc. |
Multivalent protein conjugate with multiple ligand-binding domains of receptors
|
|
WO2003031481A2
(en)
|
2001-10-12 |
2003-04-17 |
Carnegie Mellon University |
Simultaneous reverse and normal initiation of atrp
|
|
WO2003031480A2
(en)
|
2001-10-12 |
2003-04-17 |
Carnegie Mellon University |
Process for monomer sequence control in polymerizations
|
|
WO2003033521A1
(en)
|
2001-10-16 |
2003-04-24 |
Massachusetts Institute Of Technology |
Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides.
|
|
EP1446438A2
(en)
|
2001-11-07 |
2004-08-18 |
Nektar Therapeutics Al, Corporation |
Branched polymers and their conjugates
|
|
HRP20040406A2
(en)
|
2001-11-09 |
2005-02-28 |
Eyetech Pharmaceuticals |
Methods for treating ocular neovascular diseases
|
|
BRPI0214168B8
(pt)
|
2001-11-14 |
2021-05-25 |
Centocor Inc |
anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos
|
|
US8048408B2
(en)
|
2002-01-16 |
2011-11-01 |
Biocompatibles Uk Limited |
Polymer conjugates
|
|
GB0202494D0
(en)
|
2002-02-02 |
2002-03-20 |
Avecia Ltd |
Process
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
AU2003217009A1
(en)
|
2002-03-07 |
2003-09-16 |
Biocompatibles Uk Limited |
Compositions of polymers
|
|
AU2003214387A1
(en)
|
2002-03-07 |
2003-09-16 |
Biocompatibles Uk Limited |
Drug carriers comprising amphiphilic block copolymers
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
CA2479212A1
(en)
|
2002-03-15 |
2003-09-25 |
Brigham And Women's Hospital, Inc. |
Central airway administration for systemic delivery of therapeutics
|
|
EP1490113A4
(en)
|
2002-03-20 |
2007-05-02 |
Univ Florida |
RAAV VECTOR COMPOSITIONS AND METHOD FOR TREATING CHOROIDAL NEOVASCULARIZATION
|
|
US7196142B2
(en)
|
2002-04-04 |
2007-03-27 |
The University Of Akron |
Polyisobutylene-based block anionomers and cationomers and synthesis thereof
|
|
JP4248189B2
(ja)
|
2002-04-09 |
2009-04-02 |
株式会社資生堂 |
ホスホリルコリン基含有多糖類及びその製造方法
|
|
WO2003099835A1
(en)
|
2002-05-21 |
2003-12-04 |
Emory University |
Multivalent polymers with chain-terminating binding groups
|
|
US7375234B2
(en)
|
2002-05-30 |
2008-05-20 |
The Scripps Research Institute |
Copper-catalysed ligation of azides and acetylenes
|
|
WO2004003144A2
(en)
|
2002-07-01 |
2004-01-08 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to reg iv
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
ES2369542T3
(es)
|
2002-07-31 |
2011-12-01 |
Seattle Genetics, Inc. |
Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa.
|
|
EP1534764B1
(en)
|
2002-08-09 |
2014-07-16 |
Carnegie Mellon University |
Polymers, supersoft elastomers and methods for preparing the same
|
|
US20040247588A1
(en)
|
2002-08-28 |
2004-12-09 |
Johnson Robert E. |
Formulations of modified antibodies and methods of making the same
|
|
US20040091490A1
(en)
|
2002-08-28 |
2004-05-13 |
Robert Johnson |
Stable pH optimized formulation of a modified antibody
|
|
SI1539157T1
(sl)
|
2002-09-18 |
2013-11-29 |
Trustees Of The University Of Pennsylvania |
Rapamicin za uporabo pri inhibiciji ali preprečevanju horoidalne neovaskularizacije
|
|
US20060165804A1
(en)
|
2002-09-25 |
2006-07-27 |
Lewis Andrew L |
Polymer compositions for administration to animals
|
|
WO2004044023A1
(fr)
|
2002-11-07 |
2004-05-27 |
Rhodia Chimie |
Copolymere a structure controlee presentant une partie amphotere ou zwitterionique.
|
|
US20070111279A1
(en)
|
2002-11-13 |
2007-05-17 |
Procell, Inc. |
Production of recombinant therapeutic bioscavengers against chemical and biological agents
|
|
GB0228409D0
(en)
|
2002-12-06 |
2003-01-08 |
Thromb X Nv |
Pharmacological vitreolysis
|
|
GB0301014D0
(en)
|
2003-01-16 |
2003-02-19 |
Biocompatibles Ltd |
Conjugation reactions
|
|
EP1598368A4
(en)
|
2003-01-20 |
2007-07-25 |
Chugai Pharmaceutical Co Ltd |
ANTI-PCI neutralizing ANTIBODY
|
|
WO2004065417A2
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
|
EP2267049A1
(en)
|
2003-02-05 |
2010-12-29 |
Biocompatibles UK Limited |
Block copolymers
|
|
CN103040732B
(zh)
|
2003-02-10 |
2015-04-01 |
伊兰药品公司 |
免疫球蛋白制剂及其制备方法
|
|
US7662387B2
(en)
|
2003-02-20 |
2010-02-16 |
Seattle Genetics |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
|
US20060231107A1
(en)
|
2003-03-07 |
2006-10-19 |
Glickman Randolph D |
Antibody-targeted photodynamic therapy
|
|
JP4730909B2
(ja)
|
2003-03-28 |
2011-07-20 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Ｖｅｇｆ媒介性活性を遮断することにより糖尿病を処置する方法
|
|
US20050074497A1
(en)
|
2003-04-09 |
2005-04-07 |
Schultz Clyde L. |
Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
|
|
US20120183593A1
(en)
|
2003-04-09 |
2012-07-19 |
Directcontact Llc |
Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
|
|
US9040664B2
(en)
|
2003-04-11 |
2015-05-26 |
Antriabio, Inc. |
Materials and methods for preparing protein-polymer conjugates
|
|
US20040266688A1
(en)
|
2003-05-14 |
2004-12-30 |
Nayak Nihar R |
Methods for modulating endometrium
|
|
KR20060080535A
(ko)
|
2003-05-14 |
2006-07-10 |
이뮤노젠 아이엔씨 |
약물 콘쥬게이트 조성물
|
|
US20050239088A1
(en)
|
2003-05-16 |
2005-10-27 |
Shepard H M |
Intron fusion proteins, and methods of identifying and using same
|
|
PT2644206T
(pt)
|
2003-05-23 |
2019-07-10 |
Nektar Therapeutics |
Derivados de peg contendo duas cadeias de peg
|
|
AU2004242586C1
(en)
|
2003-05-28 |
2011-02-24 |
Regeneron Pharmaceuticals, Inc. |
Method of treating corneal transplant rejection by using VEGF antagonists
|
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
|
CA2519875C
(en)
|
2003-06-06 |
2014-01-14 |
Regeneron Pharmaceuticals, Inc. |
Method of tumor regression with vegf inhibitors
|
|
GB0314472D0
(en)
|
2003-06-20 |
2003-07-23 |
Warwick Effect Polymers Ltd |
Polymer
|
|
AR046510A1
(es)
|
2003-07-25 |
2005-12-14 |
Regeneron Pharma |
Composicion de un antagonista de vegf y un agente anti-proliferativo
|
|
CN1208358C
(zh)
|
2003-07-31 |
2005-06-29 |
上海交通大学 |
含多羟基官能团多臂星状超支化聚合物刷及其制备方法
|
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
US7758859B2
(en)
|
2003-08-01 |
2010-07-20 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
EP1651670A2
(en)
|
2003-08-04 |
2006-05-03 |
Applied Research Systems ARS Holding N.V. |
Novel therapeutic fusion proteins
|
|
JP2007501239A
(ja)
|
2003-08-06 |
2007-01-25 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
放射線治療と組み合わせたｖｅｇｆアンタゴニストの使用
|
|
NZ592039A
(en)
|
2003-08-27 |
2013-03-28 |
Ophthotech Corp |
Combination therapy for the treatment of ocular neovascular disorders
|
|
CN1852740B
(zh)
|
2003-09-17 |
2011-05-11 |
耐科塔医药公司 |
多支链聚合物的药物前体
|
|
CA2543360A1
(en)
|
2003-10-24 |
2005-05-06 |
Joost A. Kolkman |
Ldl receptor class a and egf domain monomers and multimers
|
|
ES2605443T3
(es)
|
2003-11-06 |
2017-03-14 |
Seattle Genetics, Inc. |
Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
|
|
JP2005141865A
(ja)
|
2003-11-07 |
2005-06-02 |
Toyota Motor Corp |
高密度記録媒体
|
|
US20050100550A1
(en)
|
2003-11-10 |
2005-05-12 |
Mohit Trikha |
Anti-angiogenic uses of IL-6 antagonists
|
|
BRPI0406605B8
(pt)
|
2003-11-13 |
2021-05-25 |
Hanmi Holdings Co Ltd |
conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
|
|
CN1925875A
(zh)
|
2003-12-16 |
2007-03-07 |
尼克塔治疗亚拉巴马公司 |
化学改性的小分子
|
|
US8298532B2
(en)
|
2004-01-16 |
2012-10-30 |
Regeneron Pharmaceuticals, Inc. |
Fusion polypeptides capable of activating receptors
|
|
US7127655B2
(en)
|
2004-01-20 |
2006-10-24 |
Qualcomm, Inc. |
Methods and apparatus to optimize delivery of multicast content using probabilistic feedback
|
|
EP1708752B1
(en)
|
2004-01-27 |
2012-02-22 |
University Of Southern California |
Polymer-bound antibody cancer therapeutic agent
|
|
KR100593443B1
(ko)
|
2004-02-11 |
2006-06-28 |
삼성전자주식회사 |
트랜지스터들 및 그 제조방법들
|
|
CA2556752C
(en)
|
2004-02-23 |
2016-02-02 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
JP4727938B2
(ja)
|
2004-02-24 |
2011-07-20 |
泰彦 岩崎 |
リビングラジカル重合開始基を持つポリリン酸の製造方法および用途
|
|
US20050282233A1
(en)
|
2004-03-05 |
2005-12-22 |
Ludwig Institute For Cancer Research |
Multivalent antibody materials and methods for VEGF/PDGF family of growth factors
|
|
US7422741B2
(en)
|
2004-03-05 |
2008-09-09 |
Vegenics Limited |
VEGFR-3 fusion proteins
|
|
JP4727941B2
(ja)
|
2004-03-12 |
2011-07-20 |
泰彦 岩崎 |
生分解性重合体の製造方法および用途
|
|
US20050208093A1
(en)
|
2004-03-22 |
2005-09-22 |
Thierry Glauser |
Phosphoryl choline coating compositions
|
|
CA2786794C
(en)
|
2004-03-23 |
2017-09-12 |
Complex Biosystems Gmbh |
Aromatic polymeric cascade prodrug linker reagent
|
|
US20060182783A1
(en)
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
US20050244472A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US20070059336A1
(en)
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
|
GB0412181D0
(en)
|
2004-06-01 |
2004-06-30 |
Celltech R&D Ltd |
Biological products
|
|
ES2381014T3
(es)
|
2004-06-08 |
2012-05-22 |
Chengdu Kanghong Biotechnologies Co., Ltd. |
Proteína quimérica inhibidora de la angiogénesis y el uso
|
|
US20100062001A1
(en)
|
2004-06-09 |
2010-03-11 |
Technion Research & Development |
Antibodies for selective apoptosis of cells
|
|
EP2583685A1
(en)
|
2004-06-10 |
2013-04-24 |
Regeneron Pharmaceuticals, Inc. |
Method of administering and using VEGF inhibitors for the treatment of human cancer
|
|
US7863238B2
(en)
|
2004-06-10 |
2011-01-04 |
Saint Louis University |
Proteins with an attached short peptide of acidic amino acids
|
|
EP1755645A2
(en)
|
2004-06-18 |
2007-02-28 |
Regeneron Pharmaceuticals, Inc. |
Vegf inhibitors for the treatment of malignant pleural effusion
|
|
US20080096923A1
(en)
|
2004-07-23 |
2008-04-24 |
Aniz Girach |
Methods For Diagnosing And Treating Diabetic Microvascular Complications
|
|
CN1997386B
(zh)
|
2004-07-30 |
2012-05-30 |
瑞泽恩制药公司 |
通过阻断vegf介导的活性来治疗i型糖尿病的方法
|
|
NZ553162A
(en)
|
2004-08-16 |
2010-03-26 |
Quark Biotech Inc |
Double stranded siRNA compounds that inhibit RRTP801
|
|
CA2577133A1
(en)
|
2004-08-19 |
2006-03-23 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
CN101094688B
(zh)
|
2004-09-13 |
2013-05-01 |
建新公司 |
多聚构建体
|
|
TR201808537T4
(tr)
|
2004-09-23 |
2018-07-23 |
Genentech Inc |
Sistein değiştirilmiş antikorlar ve konjugatlar.
|
|
WO2006037106A2
(en)
|
2004-09-24 |
2006-04-06 |
Rfe Pharma Llc |
Carboxy-amido-triazoles for the localized treatment of ocular diseases
|
|
MX2007004374A
(es)
|
2004-10-12 |
2008-01-29 |
Amprotein Corp |
Proteina quimerica.
|
|
WO2006044643A2
(en)
|
2004-10-15 |
2006-04-27 |
Seattle Genetics, Inc. |
Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
PT1802334E
(pt)
|
2004-10-21 |
2012-11-28 |
Genentech Inc |
Método para tratamento de doenças neovasculares intraoculares
|
|
US8048418B2
(en)
|
2004-10-29 |
2011-11-01 |
Regeneron Pharmaceuticals, Inc. |
Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists
|
|
DK2371856T3
(en)
|
2004-11-12 |
2022-08-08 |
Bayer Healthcare Llc |
Site-directed modifikation af FVIII
|
|
US7214759B2
(en)
|
2004-11-24 |
2007-05-08 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same
|
|
FR2878749B1
(fr)
|
2004-12-03 |
2007-12-21 |
Aventis Pharma Sa |
Combinaisons antitumorales contenant en agent inhibiteur de vegt et du 5fu ou un de ses derives
|
|
WO2006063055A2
(en)
|
2004-12-06 |
2006-06-15 |
Bolder Biotechnology, Inc. |
Enzyme conjugates for use as detoxifying agents
|
|
US20060257396A1
(en)
|
2004-12-15 |
2006-11-16 |
Jacobsen Jack S |
Abeta antibodies for use in improving cognition
|
|
EP1672192B1
(en)
|
2004-12-18 |
2007-08-08 |
Haldor Topsoe A/S |
Method for controlling injection of reducing agent in exhaust gas from a combustion engine
|
|
US8211864B2
(en)
|
2005-01-26 |
2012-07-03 |
Medical College Of Georgia Research Institute |
Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors
|
|
US20080248030A1
(en)
|
2005-02-02 |
2008-10-09 |
Children's Medical Center Corporation |
Method of Treating Angiogenic Diseases
|
|
EP1877438A2
(en)
|
2005-02-02 |
2008-01-16 |
Regeneron Pharmaceuticals, Inc. |
Method of treating eye injury with local administration of a vegf inhibitor
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
EP1853298A2
(en)
|
2005-02-11 |
2007-11-14 |
Regeneron Pharmaceuticals, Inc. |
Therapeutic combination of a vegf antagonist (vegf trap) and an anti-hypertensive agent
|
|
WO2006091666A2
(en)
|
2005-02-23 |
2006-08-31 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for treating conditions of the eye
|
|
EP2289532A1
(en)
|
2005-02-28 |
2011-03-02 |
Oncotherapy Science, Inc. |
Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
|
|
MX2007010833A
(es)
|
2005-03-07 |
2009-02-17 |
Univ Chicago |
Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales.
|
|
CA2600024A1
(en)
|
2005-03-07 |
2006-09-14 |
The Trustees Of Boston University |
Diagnostic and therapeutic target for macular degeneration
|
|
WO2006096489A2
(en)
|
2005-03-08 |
2006-09-14 |
Pharmacia & Upjohn Company Llc |
Anti-m-csf antibody compositions having reduced levels of endotoxin
|
|
JP5737826B2
(ja)
|
2005-03-11 |
2015-06-17 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Ｖｅｇｆの阻害による貧血の処置
|
|
CA3142945A1
(en)
|
2005-03-25 |
2006-10-05 |
Regeneron Pharmaceuticals, Inc. |
Histidine-buffered formulations of vegf antagonist
|
|
US20060234347A1
(en)
|
2005-04-13 |
2006-10-19 |
Harding Thomas C |
Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
|
|
WO2006118547A1
(en)
|
2005-04-29 |
2006-11-09 |
Agency For Science, Technology And Research |
Hyperbranched polymers and their applications
|
|
PA8672101A1
(es)
|
2005-04-29 |
2006-12-07 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, métodos y usos
|
|
US20070005130A1
(en)
|
2005-06-29 |
2007-01-04 |
Thierry Glauser |
Biodegradable polymer for coating
|
|
WO2007011873A2
(en)
|
2005-07-15 |
2007-01-25 |
Genentech, Inc. |
Method for treating intraocular neovascular diseases
|
|
WO2008020827A2
(en)
|
2005-08-01 |
2008-02-21 |
Biogen Idec Ma Inc. |
Altered polypeptides, immunoconjugates thereof, and methods related thereto
|
|
US20110076278A1
(en)
|
2005-08-02 |
2011-03-31 |
Mehran Khodadoust |
Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders
|
|
AU2006279658A1
(en)
|
2005-08-12 |
2007-02-22 |
Regeneron Pharmaceuticals, Inc. |
Treatment of diseases by subcutaneous administration of a VEGF antagonist
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
AU2006279541A1
(en)
|
2005-08-15 |
2007-02-22 |
The Regents Of The University Of California |
VEGF-activated FAS ligands
|
|
CA2619725C
(en)
|
2005-08-18 |
2016-06-07 |
Ramot At Tel Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
|
WO2007025310A1
(en)
|
2005-08-26 |
2007-03-01 |
Carnegie Mellon University |
Polymerization process with catalyst reactivation
|
|
US20080167600A1
(en)
|
2005-09-26 |
2008-07-10 |
Peyman Gholam A |
Device for delivery of an agent to the eye and other sites
|
|
US20070071756A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an agent to ameliorate inflammation
|
|
WO2007041614A2
(en)
|
2005-10-03 |
2007-04-12 |
Bolder Biotechnology, Inc. |
Long acting vegf inhibitors and methods of use
|
|
WO2007047626A1
(en)
|
2005-10-14 |
2007-04-26 |
Alcon, Inc. |
Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis
|
|
EP1968594B1
(en)
|
2005-11-29 |
2010-09-29 |
GlaxoSmithKline LLC |
Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
|
|
WO2007075534A2
(en)
|
2005-12-16 |
2007-07-05 |
Nektar Therapeutics Al, Corporation |
Polymer conjugates of glp-1
|
|
JP2009519962A
(ja)
|
2005-12-19 |
2009-05-21 |
コメンティス，インコーポレーテッド |
眼投与用局所メカミルアミン製剤およびその使用
|
|
US7906134B2
(en)
|
2005-12-21 |
2011-03-15 |
Abbott Laboratories |
Room temperature-curable polymers
|
|
CA2622312A1
(en)
|
2006-01-30 |
2007-08-02 |
(Osi) Eyetech, Inc. |
Combination therapy for the treatment of neovascular disorders
|
|
WO2007097839A2
(en)
|
2006-02-16 |
2007-08-30 |
Massachusetts Eye And Ear Infirmary |
Ansamycin analogs or heat shock 90 inhibitors in combination with pdt treatin conditions of the eye
|
|
DE102006009004A1
(de)
|
2006-02-23 |
2007-09-06 |
Sustech Gmbh & Co. Kg |
Multifunktionelle sternförmige Präpolymere, deren Herstellung und Verwendung
|
|
SI1988910T1
(en)
|
2006-02-28 |
2018-02-28 |
Kodiak Sciences Inc. |
Polymeric conjugates containing acryloyloxyethylphosphorylcholine and their preparations
|
|
DK1991275T3
(en)
|
2006-03-08 |
2014-12-08 |
Archemix Llc |
Complement aptamers AND ANTI-C5 AGENTS FOR USE IN THE TREATMENT OF EYE DISEASES
|
|
US7354582B2
(en)
|
2006-03-10 |
2008-04-08 |
Regeneron Pharmaceuticals, Inc. |
Use of VEGF antagonists for the treatment of malignant gliomas
|
|
US20090053137A1
(en)
|
2006-03-15 |
2009-02-26 |
Moore Dennis A |
Chelating Conjugates Having a Substituted Aromatic Moiety and Derivatives Thereof
|
|
WO2007109244A2
(en)
|
2006-03-21 |
2007-09-27 |
Morehouse School Of Medicine |
Novel nanoparticles for delivery of active agents
|
|
AR060040A1
(es)
|
2006-03-21 |
2008-05-21 |
Genentech Inc |
Antagonistas de vefg y de alfa5 beta 1
|
|
JP2007263935A
(ja)
|
2006-03-30 |
2007-10-11 |
Canon Inc |
磁性マーカー及びその製造方法
|
|
US8216575B2
(en)
|
2006-03-31 |
2012-07-10 |
Chengdu Kanghong Biotechnologies Co., Ltd. |
Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
|
|
GB0620255D0
(en)
|
2006-10-12 |
2006-11-22 |
Fusion Antibodies Ltd |
Antibody and uses thereof
|
|
US8445016B2
(en)
|
2006-04-14 |
2013-05-21 |
Interface Biologics, Inc. |
Grafted polymers and uses thereof
|
|
US8147828B2
(en)
|
2006-04-17 |
2012-04-03 |
Ludwig Institute For Cancer Research |
Methods and compositions for modulation of blood-neural barrier
|
|
CA2653748A1
(en)
|
2006-05-02 |
2007-11-15 |
Allozyne, Inc. |
Non-natural amino acid substituted polypeptides
|
|
US20070258976A1
(en)
|
2006-05-04 |
2007-11-08 |
Ward Keith W |
Combination Therapy for Diseases Involving Angiogenesis
|
|
AU2007247426B2
(en)
|
2006-05-04 |
2012-03-08 |
Fondation Ophthalmologique Adolf De Rothschild |
Combination comprising a VEGF inhibitor and a serine protease for treating neovascular diseases
|
|
JP5030036B2
(ja)
|
2006-05-23 |
2012-09-19 |
一彦 石原 |
生体成分固定化ポリマー組成物および三次元架橋体
|
|
JP2009540011A
(ja)
|
2006-06-12 |
2009-11-19 |
エクセジェニックス、インク．ディー／ビー／エー オプコ ヘルス、インク． |
血管新生のｓｉＲＮＡ阻害のための組成物及び方法
|
|
CA2654510C
(en)
|
2006-06-16 |
2015-03-17 |
Regeneron Pharmaceuticals, Inc. |
Vegf antagonist formulations suitable for intravitreal administration
|
|
EP2038320B1
(en)
|
2006-06-29 |
2014-03-12 |
Life Technologies AS |
Particles containing multi- block polymers
|
|
US20080008736A1
(en)
|
2006-07-06 |
2008-01-10 |
Thierry Glauser |
Random copolymers of methacrylates and acrylates
|
|
JP5179487B2
(ja)
|
2006-07-14 |
2013-04-10 |
バイオコンパティブルズ ユーケー リミテッド |
ポリマー
|
|
CN101500548A
(zh)
|
2006-08-18 |
2009-08-05 |
弗·哈夫曼-拉罗切有限公司 |
用于体内递送多核苷酸的多缀合物
|
|
KR100808116B1
(ko)
|
2006-08-22 |
2008-03-03 |
전남대학교산학협력단 |
미생물 점착 방지용 공중합체 수지 코팅재
|
|
US20100056428A1
(en)
|
2006-09-01 |
2010-03-04 |
Novo Nordisk Health Care Ag |
Modified proteins
|
|
US20080070855A1
(en)
|
2006-09-20 |
2008-03-20 |
James Pitzer Gills |
Treatment with anti-VEGF agents to prevent postoperative inflammation and angiogenesis in normal and diseased eyes
|
|
CA2666974A1
(en)
|
2006-10-20 |
2008-11-06 |
Schering Corporation |
Fully human anti-vegf antibodies and methods of using
|
|
CU23636A1
(es)
|
2006-11-01 |
2011-03-21 |
Ct Ingenieria Genetica Biotech |
Anticuerpos recombinantes contra el factor de crecimiento del endotelio vascular (vegf)
|
|
JP5111016B2
(ja)
|
2006-11-01 |
2012-12-26 |
三井化学株式会社 |
表面親水性ポリオレフィン成形体およびその製造方法
|
|
CN106084055A
(zh)
|
2006-11-02 |
2016-11-09 |
健泰科生物技术公司 |
人源化的抗‑d因子抗体
|
|
US20110038856A1
(en)
|
2006-11-02 |
2011-02-17 |
Seattle Genetics, Inc. |
Methods of treating neoplastic, autoimmune and inflammatory diseases
|
|
US8039010B2
(en)
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
|
CA2666709A1
(en)
|
2006-11-10 |
2008-05-29 |
Genentech, Inc. |
Method for treating age-related macular degeneration
|
|
US20080118500A1
(en)
|
2006-11-16 |
2008-05-22 |
Taiwan Liposome Company |
Sustained releasing composition via local injection for treating eye diseases
|
|
WO2008064058A2
(en)
|
2006-11-21 |
2008-05-29 |
Abbott Laboratories |
Use of a terpolymer of tetrafluoroethylene, hexafluoropropylene, and vinylidene fluoride in drug eluting coatings
|
|
PL2099823T5
(pl)
|
2006-12-01 |
2023-02-20 |
Seagen Inc. |
Wariant środków wiążących cel i jego zastosowania
|
|
WO2008070479A2
(en)
|
2006-12-01 |
2008-06-12 |
Allergan, Inc. |
Method for determining optimum intraocular locations for drug delivery systems
|
|
US7651527B2
(en)
|
2006-12-15 |
2010-01-26 |
Medtronic Vascular, Inc. |
Bioresorbable stent
|
|
JP5419709B2
(ja)
|
2007-01-09 |
2014-02-19 |
ワイス・エルエルシー |
抗ｉｌ−１３抗体製剤およびその使用
|
|
EP2125016A2
(en)
|
2007-02-01 |
2009-12-02 |
Genetech, Inc. |
Combination therapy with angiogenesis inhibitors
|
|
EP2114327A1
(en)
|
2007-02-14 |
2009-11-11 |
Opto Global Holdings Pty Ltd. |
Methods and systems of treating age-related macular degeneration
|
|
EP2118150B1
(en)
|
2007-02-14 |
2015-09-23 |
Biocompatibles UK Limited |
Derivatisation of biological molecules
|
|
US10259860B2
(en)
|
2007-02-27 |
2019-04-16 |
Aprogen Inc. |
Fusion proteins binding to VEGF and angiopoietin
|
|
WO2008112289A2
(en)
|
2007-03-12 |
2008-09-18 |
Nektar Therapeutics |
Oligomer-protease inhibitor conjugates
|
|
US20100152201A1
(en)
|
2007-03-12 |
2010-06-17 |
Nektar Therapeutics |
Oligomer-Antihistamine Conjugates
|
|
WO2008119565A2
(en)
|
2007-04-03 |
2008-10-09 |
Micromet Ag |
Cross-species-specific binding domain
|
|
WO2008119567A2
(en)
|
2007-04-03 |
2008-10-09 |
Micromet Ag |
Cross-species-specific cd3-epsilon binding domain
|
|
CN101053681B
(zh)
|
2007-04-10 |
2010-05-19 |
天津大学 |
用于血管栓塞材料的温敏性MPC-b-NIPAM二嵌段星型共聚物及制备方法和应用
|
|
EA019595B1
(ru)
|
2007-04-17 |
2014-04-30 |
Имклоун Элэлси |
СПЕЦИФИЧНЫЕ ИНГИБИТОРЫ PDGFRβ
|
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
RU2009144142A
(ru)
|
2007-04-30 |
2011-06-10 |
Алькон Рисерч, Лтд. (Us) |
Лечение возрастной дегенерации желтого пятна с применением ингибиторов фактора d комплемента
|
|
US11078262B2
(en)
|
2007-04-30 |
2021-08-03 |
Allergan, Inc. |
High viscosity macromolecular compositions for treating ocular conditions
|
|
EP2214710A1
(en)
|
2007-05-07 |
2010-08-11 |
Gammacan |
Human anti-vegf polyclonal antibodies and uses thereof
|
|
PE20090245A1
(es)
|
2007-05-08 |
2009-03-17 |
Genentech Inc |
Anticuerpos anti-muc16 disenados con cisteina y conjugados de anticuerpos y farmacos
|
|
DK2152293T3
(en)
|
2007-05-11 |
2017-02-06 |
Univ Nebraska |
COMPOSITIONS FOR PROTEIN GIVING AND PROCEDURES FOR USE THEREOF
|
|
CA2684153A1
(en)
|
2007-05-14 |
2008-11-27 |
Tyco Healthcare Group Lp |
Furanone copolymers
|
|
US7985557B2
(en)
|
2007-05-23 |
2011-07-26 |
Ventana Medical Systems, Inc. |
Polymeric carriers for immunohistochemistry and in situ hybridization
|
|
JP5019524B2
(ja)
|
2007-06-01 |
2012-09-05 |
国立大学法人 東京大学 |
新規ポリ（メタ）アクリレート共重合体ならびに小胞体及びゴルジ体への送達方法
|
|
CA2688434A1
(en)
|
2007-06-06 |
2008-12-11 |
Domantis Limited |
Polypeptides, antibody variable domains and antagonists
|
|
GB0724331D0
(en)
|
2007-12-13 |
2008-01-23 |
Domantis Ltd |
Compositions for pulmonary delivery
|
|
US8563521B2
(en)
|
2007-06-21 |
2013-10-22 |
Technische Universitat Munchen |
Biological active proteins having increased in vivo and/or in vitro stability
|
|
EP2586788B1
(en)
|
2007-07-09 |
2017-11-29 |
Genentech, Inc. |
Prevention of disulfide bond reduction during recombinant production of polypeptides
|
|
US20100196435A1
(en)
|
2007-07-10 |
2010-08-05 |
The Regents Of The University Of California |
Materials and methods for delivering compositions to selected tissues
|
|
PT2474557E
(pt)
|
2007-07-16 |
2014-12-03 |
Genentech Inc |
Anticorpos e imunoconjugados anti-cd79b e métodos de utilização
|
|
JP2009042617A
(ja)
|
2007-08-10 |
2009-02-26 |
Canon Inc |
静電荷像現像用トナー及びその製造方法
|
|
WO2009026158A2
(en)
|
2007-08-16 |
2009-02-26 |
Carnegie Mellon University |
Inflammation-regulating compositions and methods
|
|
US7943370B2
(en)
|
2007-08-23 |
2011-05-17 |
Canon Kabushiki Kaisha |
Structure, target substance detection element and target substance detection kit
|
|
AR066170A1
(es)
|
2007-09-26 |
2009-07-29 |
Genentech Inc |
Anti integrina alfa 5 beta 1
|
|
WO2009048780A1
(en)
|
2007-10-08 |
2009-04-16 |
The University Of Kentucky Research Foundation |
Polymer-metal chelator conjugates and uses thereof
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
BRPI0818780A2
(pt)
|
2007-10-19 |
2015-04-22 |
Genentech Inc |
Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos
|
|
RU2010120674A
(ru)
|
2007-10-22 |
2011-11-27 |
Шеринг Корпорейшн (US) |
Полностью человеческие анти-vegf-антитела и способы их применения
|
|
WO2009053368A1
(en)
|
2007-10-22 |
2009-04-30 |
Merck Serono S.A. |
Single ifn-beta fused to a mutated igg fc fragment
|
|
JP2009114283A
(ja)
|
2007-11-05 |
2009-05-28 |
Asahi Kasei Chemicals Corp |
吸引用シートおよびそれを用いた装置
|
|
CL2008003302A1
(es)
|
2007-11-09 |
2009-03-06 |
Genentech Inc |
Uso de una proteina de funsion kinasa 1 similar al receptor de activina (alk-1) y fc (alk1.fc) porque sirve para preparar un medicamento contra tumor,cancer o desordenes proliferativos.
|
|
WO2009060198A1
(en)
|
2007-11-09 |
2009-05-14 |
Peregrine Pharmaceuticals, Inc. |
Anti-vegf antibody compositions and methods
|
|
GB0722484D0
(en)
|
2007-11-15 |
2007-12-27 |
Ucl Business Plc |
Solid compositions
|
|
EP2226075A1
(en)
|
2007-11-22 |
2010-09-08 |
The University of Tokyo |
Material for preventing tissue adhesion and material for preventing joint contracture
|
|
BRPI0819856B1
(pt)
|
2007-11-28 |
2019-09-17 |
Tocalo Co., Ltd. |
Cilindro de soleira em um forno de recozimento contínuo e seu método de produção
|
|
TWI468417B
(zh)
|
2007-11-30 |
2015-01-11 |
Genentech Inc |
抗－ｖｅｇｆ抗體
|
|
KR20100107501A
(ko)
|
2008-01-18 |
2010-10-05 |
메디뮨 엘엘씨 |
부위 특이적 접합을 위한 시스테인 조작 항체
|
|
US8114289B2
(en)
|
2008-01-29 |
2012-02-14 |
California Institute Of Technology |
Method and apparatus for microfiltration to perform cell separation
|
|
DK2657253T3
(en)
|
2008-01-31 |
2017-10-09 |
Genentech Inc |
Anti-CD79b antibodies and immune conjugates and methods of use
|
|
CN101951925A
(zh)
|
2008-02-20 |
2011-01-19 |
建新公司 |
血管发生抑制
|
|
CA2716110A1
(en)
|
2008-02-21 |
2009-08-27 |
Tim Mcnamara |
Ophthalmic nsaids as adjuvants
|
|
US20090220434A1
(en)
|
2008-02-29 |
2009-09-03 |
Florida State University Research Foundation |
Nanoparticles that facilitate imaging of biological tissue and methods of forming the same
|
|
US8557246B2
(en)
|
2008-03-14 |
2013-10-15 |
Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria |
Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof
|
|
WO2009117531A1
(en)
|
2008-03-18 |
2009-09-24 |
Seattle Genetics, Inc. |
Auristatin drug linker conjugates
|
|
BRPI0822556B1
(pt)
|
2008-03-26 |
2022-03-03 |
Epitomics, Inc |
Anticorpo monoclonal anti-vegf e composição farmacêutica
|
|
JP5425180B2
(ja)
|
2008-03-27 |
2014-02-26 |
ザイモジェネティクス， インコーポレイテッド |
ＰＤＧＦＲβおよびＶＥＧＦ−Ａを阻害するための組成物および方法
|
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
|
EP2282769A4
(en)
|
2008-04-29 |
2012-04-25 |
Abbott Lab |
DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND ITS USES
|
|
US20100260668A1
(en)
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
|
US7740844B2
(en)
|
2008-04-29 |
2010-06-22 |
Taiwan Liposome Co. Ltd |
Anti-VEGF monoclonal antibody
|
|
NZ588884A
(en)
|
2008-04-30 |
2013-05-31 |
Immunogen Inc |
Cross-linkers and their uses
|
|
US9732142B2
(en)
|
2008-05-15 |
2017-08-15 |
Biocompatibles Uk Limited |
Intracellular antibody delivery
|
|
JP5344420B2
(ja)
|
2008-05-15 |
2013-11-20 |
独立行政法人国立循環器病研究センター |
遺伝子導入剤及びその製造方法並びに核酸複合体
|
|
WO2009139905A2
(en)
|
2008-05-16 |
2009-11-19 |
Nektar Therapeutics |
Conjugates of a cholinesterase moiety and a polymer
|
|
EP2297209A4
(en)
|
2008-06-03 |
2012-08-01 |
Abbott Lab |
IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF
|
|
WO2009149205A2
(en)
|
2008-06-03 |
2009-12-10 |
Neurotech Usa, Inc. |
Cell lines that secrete soluble vegf receptors and uses thereof
|
|
WO2009158461A1
(en)
|
2008-06-25 |
2009-12-30 |
Boston Scientific Scimed, Inc. |
Medical copolymers
|
|
KR20180005753A
(ko)
|
2008-06-25 |
2018-01-16 |
에스바테크 - 어 노바티스 컴파니 엘엘씨 |
Ｖｅｇｆ를 억제하는 안정하고 가용성인 항체
|
|
MX2011000071A
(es)
|
2008-07-02 |
2011-05-03 |
Emergent Product Dev Seattle |
Inmunoterapeuticos de interleucina-6 (il6).
|
|
US8822645B2
(en)
|
2008-07-08 |
2014-09-02 |
Abbvie Inc. |
Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
|
|
WO2010004594A1
(en)
|
2008-07-08 |
2010-01-14 |
S.I.F.I. Societa' Industria Farmaceutica Italiana S.P.A. |
Ophthalmic compositions for treating pathologies of the posterior segment of the eye
|
|
US8821870B2
(en)
|
2008-07-18 |
2014-09-02 |
Allergan, Inc. |
Method for treating atrophic age related macular degeneration
|
|
WO2010007144A2
(en)
|
2008-07-18 |
2010-01-21 |
Centre National De La Recherche Scientifique |
New mutated netrin 4 proteins, fragments thereof and their uses as drugs
|
|
TW201010829A
(en)
|
2008-09-08 |
2010-03-16 |
Mobiletron Electronics Co Ltd |
Automatic screw feeding apparatus for electricity powered screwdriver
|
|
AU2009291747B2
(en)
|
2008-09-10 |
2016-05-26 |
Genentech, Inc. |
Methods for inhibiting ocular angiogenesis
|
|
US8268314B2
(en)
|
2008-10-08 |
2012-09-18 |
Hoffmann-La Roche Inc. |
Bispecific anti-VEGF/anti-ANG-2 antibodies
|
|
AU2009303526B2
(en)
|
2008-10-14 |
2015-01-15 |
Genentech, Inc. |
Immunoglobulin variants and uses thereof
|
|
KR101719376B1
(ko)
|
2008-11-05 |
2017-03-23 |
제넨테크, 인크. |
연령-관련 황반 변성에서 유전자 다형성
|
|
EP2350264A4
(en)
|
2008-11-06 |
2012-08-29 |
Univ Johns Hopkins |
TREATMENT OF CHRONIC INFLAMMATION OF THE RESPIRATORY TRACT
|
|
JP2010117189A
(ja)
|
2008-11-12 |
2010-05-27 |
Sumitomo Bakelite Co Ltd |
生理活性物質固定化用基板
|
|
KR20110094307A
(ko)
|
2008-11-13 |
2011-08-23 |
펨타 파마슈티컬스, 인크. |
인간화된 항-ｉｌ-6 항체
|
|
KR20180117734A
(ko)
|
2008-11-22 |
2018-10-29 |
제넨테크, 인크. |
유방암의 치료를 위한, 화학요법과 조합된 항-ｖｅｇｆ 항체의 용도
|
|
KR101093717B1
(ko)
|
2008-11-26 |
2011-12-19 |
한국생명공학연구원 |
Ｖｅｇｆ―특이적인 인간항체
|
|
SG171812A1
(en)
|
2008-12-04 |
2011-07-28 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
US8802738B2
(en)
|
2008-12-12 |
2014-08-12 |
University Of Massachusetts |
Polyesters with grafted zwitterions
|
|
JP5988584B2
(ja)
|
2008-12-16 |
2016-09-07 |
キュー エル ティー インク．ＱＬＴ Ｉｎｃ． |
眼の状態に関する光線力学的療法
|
|
US8822610B2
(en)
|
2008-12-22 |
2014-09-02 |
ATRP Solutions, Inc. |
Control over controlled radical polymerization processes
|
|
WO2010075423A2
(en)
|
2008-12-23 |
2010-07-01 |
The Regents Of The University Of Michigan |
Dendrimer based modular platforms
|
|
US8349325B2
(en)
|
2008-12-23 |
2013-01-08 |
Abbott Laboratories |
Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
|
|
WO2010085542A2
(en)
|
2009-01-23 |
2010-07-29 |
Novartis Ag |
Biomarkers related to age-related macular degeneration (amd)
|
|
CN102395597A
(zh)
|
2009-03-11 |
2012-03-28 |
惠氏有限责任公司 |
纯化小模块免疫药物蛋白的方法
|
|
US8883519B1
(en)
|
2009-03-17 |
2014-11-11 |
University Of Central Florida Research Foundation, Inc. |
Oxidase activity of polymeric coated cerium oxide nanoparticles
|
|
CN101838329A
(zh)
|
2009-03-18 |
2010-09-22 |
嘉和生物药业有限公司 |
抗血管新生融合蛋白
|
|
CN103755808B
(zh)
|
2009-03-25 |
2016-02-10 |
霍夫曼-拉罗奇有限公司 |
抗-α5β1抗体及其应用
|
|
AU2010229705A1
(en)
|
2009-03-27 |
2011-10-20 |
Zymogenetics, Inc. |
Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination
|
|
GB0907251D0
(en)
|
2009-04-28 |
2009-06-10 |
Univ Leiden |
Coplymers
|
|
WO2010126552A1
(en)
|
2009-04-30 |
2010-11-04 |
Immunogen, Inc. |
Potent cell-binding agent drug conjugates
|
|
WO2010127284A2
(en)
|
2009-05-01 |
2010-11-04 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
|
JP2012525415A
(ja)
|
2009-05-01 |
2012-10-22 |
オプソテツク・コーポレイシヨン |
眼科疾患を処置または予防するための方法
|
|
CA2665956A1
(en)
|
2009-05-07 |
2010-11-07 |
Samir Patel |
Combination treatment for ocular diseases
|
|
RU2011149798A
(ru)
|
2009-05-08 |
2013-06-20 |
Дженентек, Инк. |
Гуманизированные анти-egfl7-антитела и способы их применения
|
|
SG176219A1
(en)
|
2009-05-27 |
2011-12-29 |
Hoffmann La Roche |
Tri- or tetraspecific antibodies
|
|
EA201190273A1
(ru)
|
2009-05-28 |
2012-12-28 |
Глаксо Груп Лимитед |
Комбинация антагониста tnf-альфа и антагониста vegf для применения в лечении или предупреждении заболеваний глаз
|
|
CN101575402B
(zh)
|
2009-05-31 |
2012-06-27 |
中国科学院化学研究所 |
一种多臂星型聚合物及其制备方法
|
|
EP2260873B1
(en)
|
2009-06-08 |
2019-07-24 |
Biocompatibles UK Limited |
Pcylation of proteins
|
|
RU2567639C2
(ru)
|
2009-06-17 |
2015-11-10 |
АббВай Биотерапеутикс Инк., |
Антитела против vegf и их применения
|
|
US8703132B2
(en)
|
2009-06-18 |
2014-04-22 |
Hoffmann-La Roche, Inc. |
Bispecific, tetravalent antigen binding proteins
|
|
BRPI1015234A2
(en)
|
2009-06-22 |
2018-02-20 |
Medimmune Llc |
fc regions designed for site specific conjugation.
|
|
US8956600B2
(en)
|
2009-08-10 |
2015-02-17 |
Taiwan Liposome Co. Ltd. |
Ophthalmic drug delivery system containing phospholipid and cholesterol
|
|
KR20120107069A
(ko)
|
2009-08-15 |
2012-09-28 |
제넨테크, 인크. |
이전에 치료된 유방암의 치료를 위한 항혈관신생 요법
|
|
US20190185555A1
(en)
|
2017-12-19 |
2019-06-20 |
Genentech, Inc. |
Anti-angiogenesis therapy for the treatment of previously treated breast cancer
|
|
US20180057602A1
(en)
|
2009-08-17 |
2018-03-01 |
Tracon Pharmaceuticals, Inc. |
Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents
|
|
EP2722055A1
(en)
|
2009-08-17 |
2014-04-23 |
Tracon Pharmaceuticals, Inc. |
Combination therapy with antibodies and anti-VEGF agents for the treatment of cancer
|
|
CN102002104A
(zh)
|
2009-08-28 |
2011-04-06 |
江苏先声药物研究有限公司 |
一种抗vegf的单克隆抗体及含有该抗体的药物组合物
|
|
GB0915515D0
(en)
|
2009-09-04 |
2009-10-07 |
Ucl Business Plc |
Treatment of vasculoproliferative conditions
|
|
US20110059080A1
(en)
|
2009-09-08 |
2011-03-10 |
Mark Cornfeld |
Use of an anti-il6 antibody to decrease hepcidin in cancer patients
|
|
CN102025901A
(zh)
|
2009-09-23 |
2011-04-20 |
国基电子（上海）有限公司 |
相机模组及其检测方法
|
|
RU2546008C2
(ru)
|
2009-10-21 |
2015-04-10 |
Дженентек, Инк. |
Генетические полиморфизмы при возрастной дегенерации желтого пятна
|
|
EP2493458A2
(en)
|
2009-10-30 |
2012-09-05 |
The Ohio State University |
Multi-functional biodegradable particles for selectable targeting, imaging, and therapeutic delivery and use thereof for treating ocular disorders
|
|
US20110165648A1
(en)
|
2009-11-04 |
2011-07-07 |
Menno Van Lookeren Campagne |
Co-crystal structure of factor D and anti-factor D antibody
|
|
WO2011066417A2
(en)
|
2009-11-24 |
2011-06-03 |
Carnegie Mellon University |
Antibodies and conjugates for modulators of angiogenesis
|
|
US10053513B2
(en)
|
2009-11-30 |
2018-08-21 |
Janssen Biotech, Inc. |
Antibody Fc mutants with ablated effector functions
|
|
US8486397B2
(en)
|
2009-12-11 |
2013-07-16 |
Genentech, Inc. |
Anti-VEGF-C antibodies and methods using same
|
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
|
MX2012007379A
(es)
|
2009-12-23 |
2012-08-31 |
Genentech Inc |
Anticuerpos anti-bv8 y usos de los mismos.
|
|
CA2785612C
(en)
|
2010-01-08 |
2019-09-10 |
Varleigh Immuno Pharmaceuticals (Vip) Ltd. |
Ev576 for use in the treatment of viral infections of the respiratory tract
|
|
ES2468827T3
(es)
|
2010-01-14 |
2014-06-17 |
Sanwa Kagaku Kenkyusho Co., Ltd |
Producto farmacéutico para prevenir o tratar trastornos acompañados de angiog�nesis ocular y/o permeabilidad vascular ocular elevada
|
|
US20110189174A1
(en)
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
|
WO2011096894A2
(en)
|
2010-02-04 |
2011-08-11 |
Agency For Science Technology And Research |
Use of novel markers of pluripotent stem cells
|
|
EP2536753B1
(en)
|
2010-02-16 |
2017-12-20 |
Novo Nordisk A/S |
Factor viii molecules with reduced vwf binding
|
|
WO2011101284A1
(en)
|
2010-02-16 |
2011-08-25 |
Novo Nordisk A/S |
Factor viii fusion protein
|
|
SG10201401123VA
(en)
|
2010-02-23 |
2014-08-28 |
Genentech Inc |
Anti-Angiogenesis Therapy For The Treatment Of Ovarian Cancer
|
|
WO2011116387A1
(en)
|
2010-03-19 |
2011-09-22 |
Tetragenetics, Inc. |
Production of aglycosylated monoclonal antibodies in ciliates
|
|
WO2011119656A1
(en)
|
2010-03-26 |
2011-09-29 |
Genentech, Inc. |
Anti-angiogenesis therapy for treating abdominal aortic aneurysm
|
|
TWI426920B
(zh)
|
2010-03-26 |
2014-02-21 |
Hoffmann La Roche |
雙專一性、雙價抗－ｖｅｇｆ／抗－ａｎｇ－２抗體
|
|
PT2558538T
(pt)
|
2010-04-15 |
2019-10-10 |
Kodiak Sciences Inc |
Polímeros contendo zwiterião de elevado peso molecular
|
|
US8785385B2
(en)
|
2010-04-19 |
2014-07-22 |
Research Development Foundation |
RTEF-1 variants and uses thereof
|
|
EP2575881B1
(en)
|
2010-05-28 |
2016-09-14 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
|
|
WO2011153243A2
(en)
|
2010-06-02 |
2011-12-08 |
Genentech, Inc. |
Anti-angiogenesis therapy for treating gastric cancer
|
|
RU2013104381A
(ru)
|
2010-07-02 |
2014-08-10 |
Дженентек, Инк. |
Лечение отслойки васкуляризированного пигментного эпителия терапевтическим средством против vegf
|
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
CN102311502B
(zh)
|
2010-07-10 |
2013-12-25 |
成都康弘生物科技有限公司 |
一种抑制血管新生或生长的融合蛋白及其医疗应用
|
|
WO2012009705A1
(en)
|
2010-07-15 |
2012-01-19 |
Zyngenia, Inc. |
Ang-2 binding complexes and uses thereof
|
|
JP2012025820A
(ja)
|
2010-07-21 |
2012-02-09 |
Kansai Paint Co Ltd |
親水化処理剤組成物
|
|
JP5537355B2
(ja)
|
2010-09-13 |
2014-07-02 |
株式会社大武ルート工業 |
自動ネジ締め装置
|
|
US8962804B2
(en)
|
2010-10-08 |
2015-02-24 |
City Of Hope |
Meditopes and meditope-binding antibodies and uses thereof
|
|
TWI538918B
(zh)
|
2010-10-20 |
2016-06-21 |
財團法人工業技術研究院 |
人源化之單株抗體、其核苷酸序列與其用途
|
|
WO2012059857A2
(en)
|
2010-11-01 |
2012-05-10 |
Symphogen A/S |
Pan-her antibody composition
|
|
JP2014500712A
(ja)
|
2010-11-02 |
2014-01-16 |
アッヴィ・インコーポレイテッド |
二重可変ドメイン免疫グロブリンおよびその使用
|
|
UY33707A
(es)
|
2010-11-04 |
2012-05-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
US20120156202A1
(en)
|
2010-11-05 |
2012-06-21 |
Shantha Totada R |
Age related macular degeneration treatment
|
|
US8992908B2
(en)
|
2010-11-23 |
2015-03-31 |
Alderbio Holdings Llc |
Anti-IL-6 antibodies for the treatment of oral mucositis
|
|
EP2646007B1
(en)
|
2010-12-02 |
2016-12-21 |
Neurotech USA, Inc. |
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
|
|
CU23895B1
(es)
|
2010-12-28 |
2013-05-31 |
Biorec Sa |
Anticuerpos recombinantes contra el factor de crecimiento del endotelio vascular (vegf) obtenidos mediante mutagénesis de regiones variables
|
|
KR20180023015A
(ko)
|
2011-01-13 |
2018-03-06 |
리제너론 파아마슈티컬스, 인크. |
혈관신생 눈 장애를 치료하기 위한 vegf 길항제의 용도
|
|
JP5703394B2
(ja)
|
2011-01-17 |
2015-04-15 |
エルジー・ケム・リミテッド |
新規な化合物およびこれを含む有機発光素子
|
|
WO2012105610A1
(ja)
|
2011-02-02 |
2012-08-09 |
公立大学法人名古屋市立大学 |
眼内血管新生及び／又は眼内血管透過性亢進を伴う疾患の予防又は治療のための医薬
|
|
US9125940B2
(en)
|
2011-02-03 |
2015-09-08 |
Zhuning Ma |
Compositions and methods for treating macular edema
|
|
US20130330341A1
(en)
|
2011-02-23 |
2013-12-12 |
Sanofi |
Single nucleotide polymorphisms in the promoter of vegfa gene and their use as predictive markers for anti-vegf treatments
|
|
LT2691417T
(lt)
|
2011-03-29 |
2018-10-25 |
Roche Glycart Ag |
Antikūno fc variantai
|
|
EP2699256B1
(en)
|
2011-04-21 |
2017-09-27 |
The Regents of the University of Colorado, a body corporate |
Compositions and methods for the treatment of neuromyelitis optica
|
|
JO3283B1
(ar)
|
2011-04-26 |
2018-09-16 |
Sanofi Sa |
تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
|
|
DK2714738T3
(en)
|
2011-05-24 |
2019-01-28 |
Zyngenia Inc |
MULTIVALENT AND MONOVALENT MULTISPECIFIC COMPLEXES AND THEIR APPLICATIONS
|
|
SG195196A1
(en)
|
2011-05-27 |
2013-12-30 |
Dutalys |
Dual targeting
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
KR101397088B1
(ko)
|
2011-06-10 |
2014-05-19 |
강원대학교산학협력단 |
암세포 증식 억제와 혈관신생 억제를 위한 융합 단백질 및 이를 포함한 항암 조성물
|
|
CN102250246A
(zh)
|
2011-06-10 |
2011-11-23 |
常州亚当生物技术有限公司 |
抗VEGF/PDGFRβ双特异性抗体及其应用
|
|
CA2840143A1
(en)
|
2011-06-30 |
2013-01-03 |
Gene Signal International Sa |
Composition comprising inhibitors of irs-1 and of vegf
|
|
US20130004511A1
(en)
|
2011-06-30 |
2013-01-03 |
Gene Signal International Sa |
Composition comprising inhibitors of irs-1 and of vegf
|
|
US9682144B2
(en)
|
2011-06-30 |
2017-06-20 |
Gene Signal International, Sa |
Composition comprising inhibitors of IRS-1 and of VEGF
|
|
PH12014500220A1
(en)
|
2011-07-27 |
2019-03-22 |
Glaxo Group Ltd |
Anti-vegf single variable domains fused to fc domains
|
|
JP2014525412A
(ja)
|
2011-08-17 |
2014-09-29 |
ジェネンテック， インコーポレイテッド |
難治性腫瘍における血管新生の阻害
|
|
ES2664224T3
(es)
|
2011-08-19 |
2018-04-18 |
Children's Medical Center Corporation |
Proteína de unión a VEGF para el bloqueo de la angiogénesis
|
|
US20130071394A1
(en)
|
2011-09-16 |
2013-03-21 |
John K. Troyer |
Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use
|
|
RU2619317C2
(ru)
|
2011-10-04 |
2017-05-15 |
Рума Продактс Холдинг Б.В. |
Набухающие эластомерные полимерные материалы
|
|
WO2013059137A1
(en)
|
2011-10-17 |
2013-04-25 |
Oligasis |
High molecular weight zwitterion-containing polymers
|
|
CA2853358A1
(en)
|
2011-10-24 |
2013-05-02 |
Halozyme, Inc. |
Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
|
|
JO3370B1
(ar)
|
2011-11-10 |
2019-03-13 |
Regeneron Pharma |
طريقة لتثبيط نمو الورم عن طريق تثبيط مستقبل انترلوكين 6
|
|
IL287381B2
(en)
|
2011-11-14 |
2024-04-01 |
Astellas Inst For Regenerative Medicine |
Pharmaceutical preparations of human rpe cells and uses thereof
|
|
EP2780039B9
(en)
|
2011-11-17 |
2018-04-18 |
Pfizer Inc |
Cytotoxic peptides and antibody drug conjugates thereof
|
|
AU2012340107B2
(en)
|
2011-11-18 |
2017-06-15 |
Regeneron Pharmaceuticals, Inc. |
Polymer protein microparticles
|
|
CN103134874B
(zh)
|
2011-12-01 |
2015-05-20 |
成都康弘生物科技有限公司 |
一种测定蛋白中糖基的方法
|
|
BR112014013205A2
(pt)
|
2011-12-01 |
2020-10-27 |
Protevobio, Inc. |
proteína de fusão, seu uso e seu método de produção, composição farmacêutica, ácido nucleico, e kit
|
|
US20130142796A1
(en)
|
2011-12-05 |
2013-06-06 |
Subhransu Ray |
Treatment for angiogenic disorders
|
|
SG11201402737SA
(en)
|
2011-12-05 |
2014-06-27 |
Hoffmann La Roche |
Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
|
|
EP3539982B1
(en)
|
2011-12-23 |
2025-02-19 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
CA2863986A1
(en)
|
2012-02-06 |
2013-08-15 |
The Regents Of The University Of California |
Emp2 regulates angiogenesis in cancer cells through induction of vegf
|
|
HK1205461A1
(zh)
|
2012-02-22 |
2015-12-18 |
Trustees Of Tufts College |
用於眼部传输治疗剂的组合物和方法
|
|
WO2013134414A1
(en)
|
2012-03-06 |
2013-09-12 |
Galaxy Biotech, Llc |
Bispecific antibodies with an fgf2 binding domain
|
|
PL2825558T3
(pl)
|
2012-03-13 |
2019-11-29 |
Hoffmann La Roche |
Terapia skojarzona w leczeniu raka jajnika
|
|
US9243070B2
(en)
|
2012-04-03 |
2016-01-26 |
Novelmed Therapeutics, Inc. |
Humanized and chimeric anti-factor Bb antibodies and uses thereof
|
|
WO2013155512A2
(en)
|
2012-04-13 |
2013-10-17 |
The Johns Hopkins University |
Treatment of ischemic retinopathies
|
|
PT2846836T
(pt)
|
2012-05-07 |
2019-10-29 |
Allergan Inc |
Método de tratamento de dmi em doentes refratários à terapia anti-vegf
|
|
TWI698240B
(zh)
|
2012-05-15 |
2020-07-11 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
JP6234064B2
(ja)
|
2012-05-23 |
2017-11-22 |
キヤノン株式会社 |
重合体、前記重合体を用いた核磁気共鳴分析用または磁気共鳴イメージング用の造影剤、化合物、前記重合体を用いた核磁気共鳴分析方法および磁気共鳴イメージング方法
|
|
JP5846044B2
(ja)
|
2012-05-23 |
2016-01-20 |
日油株式会社 |
（メタ）アクリル酸誘導体の製造方法
|
|
ES2742379T3
(es)
|
2012-05-31 |
2020-02-14 |
Hoffmann La Roche |
Procedimientos de tratamiento del cáncer usando antagonistas de unión al eje de PD-1 y antagonistas de VEGF
|
|
JP2015519373A
(ja)
|
2012-06-01 |
2015-07-09 |
オプソテック コーポレイションＯｐｈｔｈｏｔｅｃｈ Ｃｏｒｐｏｒａｔｉｏｎ |
抗ｐｄｇｆアプタマーおよびｖｅｇｆ拮抗薬を含む組成物
|
|
EP2861068A4
(en)
|
2012-06-01 |
2016-04-13 |
Momenta Pharmaceuticals Inc |
METHODS ASSOCIATED WITH BEVACIZUMAB
|
|
US20130323242A1
(en)
|
2012-06-01 |
2013-12-05 |
Ophthotech Corp. |
Compositions comprising an anti-pdgf aptamer and a vegf antagonist
|
|
HUE055994T2
(hu)
|
2012-06-01 |
2022-01-28 |
Novartis Ag |
Fecskendõ
|
|
US9214906B2
(en)
|
2012-07-02 |
2015-12-15 |
Skyworks Solutions, Inc. |
Systems and methods for providing high and low enable modes for controlling radio-frequency amplifiers
|
|
AU2013287119A1
(en)
|
2012-07-03 |
2015-01-22 |
Janssen Alzheimer Immunotherapy |
C-terminal and central epitope a-beta antibodies
|
|
WO2014006113A1
(en)
|
2012-07-03 |
2014-01-09 |
Sanofi |
Method of treating cancer by effective amounts of aflibercept
|
|
DE202013000688U1
(de)
|
2012-07-03 |
2013-03-05 |
Novartis Ag |
Glas-Spritze
|
|
SI3495387T1
(sl)
|
2012-07-13 |
2021-12-31 |
Roche Glycart Ag |
Bispecifična protitelesa proti VEGF/proti ANG-2 in njihova uporaba pri zdravljenju bolezni očesnih žil
|
|
US20150203591A1
(en)
|
2012-08-02 |
2015-07-23 |
Regeneron Pharmaceuticals, Inc. |
Mutivalent antigen-binding proteins
|
|
HK1206628A1
(en)
|
2012-08-02 |
2016-01-15 |
Sanofi |
Article of manufacture comprising aflibercept or ziv-aflibercept
|
|
EP3446709A1
(en)
|
2012-08-07 |
2019-02-27 |
F. Hoffmann-La Roche AG |
Combination therapy for the treatment of glioblastoma
|
|
US11458199B2
(en)
|
2012-08-21 |
2022-10-04 |
Opko Pharmaceuticals, Llc |
Liposome formulations
|
|
JP6280300B2
(ja)
|
2012-08-24 |
2018-02-14 |
中外製薬株式会社 |
脳疾患治療剤
|
|
WO2014033184A1
(en)
|
2012-08-28 |
2014-03-06 |
Novartis Ag |
Use of a vegf antagonist in treating ocular vascular proliferative diseases
|
|
US12024568B2
(en)
|
2012-09-13 |
2024-07-02 |
Cornell University |
Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
|
|
SG11201502076SA
(en)
|
2012-09-19 |
2015-04-29 |
Genentech Inc |
Methods and compositions for preventing norleucine misincorporation into proteins
|
|
WO2014049100A1
(en)
|
2012-09-28 |
2014-04-03 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical combinations comprising dual angiopoietin-2 / dll4 binders and anti-vegf agents
|
|
DK2906246T3
(da)
|
2012-10-11 |
2023-09-04 |
Ascendis Pharma Ophthalmology Div A/S |
VEGF-neutraliserende prodrugs omfattende ranibizumab til behandling af okulære tilstande, der er kendetegnet ved okulær neovaskularisering
|
|
WO2014062659A2
(en)
|
2012-10-15 |
2014-04-24 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating ocular diseases
|
|
CN104704118A
(zh)
|
2012-10-15 |
2015-06-10 |
诺和诺德保健Ag（股份有限公司） |
凝血因子vii多肽
|
|
WO2014066167A1
(en)
|
2012-10-22 |
2014-05-01 |
Fountain Biopharma Inc. |
Antibodies to interleukin-6 and uses thereof
|
|
TW201838651A
(zh)
|
2012-11-01 |
2018-11-01 |
美商艾伯維有限公司 |
穩定雙重可變區域免疫球蛋白蛋白質調配物
|
|
PE20151179A1
(es)
|
2012-11-01 |
2015-09-12 |
Abbvie Inc |
Inmunoglobulinas de dominio variable dual anti-vegf/dll4 y usos de las mismas
|
|
MX340090B
(es)
|
2012-11-05 |
2016-06-23 |
Pfizer |
Analogos de spliceostatina.
|
|
KR101763499B1
(ko)
|
2012-11-07 |
2017-07-31 |
화이자 인코포레이티드 |
항-il-13 수용체 알파 2 항체 및 항체-약물 접합체
|
|
AU2013342275B2
(en)
|
2012-11-08 |
2017-11-09 |
Clearside Biomedical, Inc. |
Methods and devices for the treatment of ocular diseases in human subjects
|
|
KR102149206B1
(ko)
|
2012-11-08 |
2020-08-31 |
세센 바이오, 아이엔씨. |
인터루킨-6의 길항제 및 이의 용도
|
|
TW201438736A
(zh)
|
2012-11-14 |
2014-10-16 |
Regeneron Pharma |
以ｄｌｌ４拮抗劑治療卵巢癌之方法
|
|
DK2924052T3
(da)
|
2012-11-21 |
2019-09-30 |
Pharmabcine Inc |
Dual-target-antistof målrettet mod vegfr-2 og dll4, og farmaceutisk sammensætning omfattende samme
|
|
US20140154255A1
(en)
|
2012-11-30 |
2014-06-05 |
Abbvie Biotherapeutics Inc. |
Anti-vegf antibodies and their uses
|
|
DK2928921T3
(da)
|
2012-12-05 |
2021-04-19 |
Novartis Ag |
Sammensætninger og fremgangsmåder til antistoffer målrettet epo
|
|
KR20150095684A
(ko)
|
2012-12-18 |
2015-08-21 |
노파르티스 아게 |
히알루로난에 결합하는 펩티드 태그를 이용하는 조성물 및 방법
|
|
WO2014100913A1
(en)
|
2012-12-24 |
2014-07-03 |
Beijing Anxinhuaide Biotech. Co., Ltd |
Improving the half life of a therapeutic polypeptide by fusing with a trimeric scaffold protein via a spacer
|
|
US10246503B2
(en)
|
2012-12-24 |
2019-04-02 |
Beijing Anxinhuaide Biotech. Co., Ltd. |
Method of improving the pharmacokinetic profile of a therapeutic polypeptide and the use thereof
|
|
CN103898101B
(zh)
|
2012-12-27 |
2017-08-08 |
上海桀蒙生物技术有限公司 |
利用转基因动物乳腺生物平台大规模生产重组人丁酰胆碱酯酶的方法
|
|
US9428575B2
(en)
|
2012-12-31 |
2016-08-30 |
Development Center For Biotechnology |
Anti-granulysin antibodies and methods of use thereof
|
|
JO3405B1
(ar)
|
2013-01-09 |
2019-10-20 |
Regeneron Pharma |
الأجسام المضادة لمضاد مستقبل عامل النمو المشتق من الصفائح الدموية - بيتا واستخداماتها
|
|
US9682154B2
(en)
|
2013-02-04 |
2017-06-20 |
Vascular Biogenics Ltd. |
Methods of inducing responsiveness to anti-angiogenic agent
|
|
SI2968461T1
(sl)
|
2013-03-13 |
2023-01-31 |
Genzyme Corporation |
Fuzijski proteini, ki vsebujejo vezavna dela PDGF in VEGF in postopek njihove uporabe
|
|
CN103193819A
(zh)
|
2013-03-13 |
2013-07-10 |
苏州蔻美新材料有限公司 |
一锅法合成mpc的方法
|
|
WO2014165181A1
(en)
|
2013-03-13 |
2014-10-09 |
The Regents Of The University Of Michigan |
Compositions for treatment of retinal detachment
|
|
US20150050277A1
(en)
|
2013-03-15 |
2015-02-19 |
Aerpio Therapeutics Inc. |
Compositions and methods for treating ocular diseases
|
|
RU2015132626A
(ru)
|
2013-03-15 |
2017-04-25 |
Слоун-Кеттеринг Инститьют Фо Кэнсэ Рисерч |
Мультимодальные наночастицы на основе диоксида кремния
|
|
KR102049990B1
(ko)
|
2013-03-28 |
2019-12-03 |
삼성전자주식회사 |
c-Met 항체 및 VEGF 결합 단편이 연결된 융합 단백질
|
|
US9603775B2
(en)
|
2013-04-24 |
2017-03-28 |
Corning Incorporated |
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
|
|
CA2904805A1
(en)
|
2013-04-29 |
2014-11-06 |
F. Hoffmann-La Roche Ag |
Fc-receptor binding modified asymmetric antibodies and methods of use
|
|
CA2904806C
(en)
|
2013-04-29 |
2021-11-23 |
F. Hoffmann-La Roche Ag |
Human fcrn-binding modified antibodies and methods of use
|
|
US9914770B2
(en)
|
2013-04-30 |
2018-03-13 |
Intas Pharmaceuticals Ltd |
Cloning, expression and purification method for the preparation of ranibizumab
|
|
KR101541478B1
(ko)
|
2013-05-31 |
2015-08-05 |
동아쏘시오홀딩스 주식회사 |
항-vegf 항체 및 이를 포함하는 암 또는 신생혈관형성관련 질환의 예방, 진단 또는 치료용 약학 조성물
|
|
WO2014196658A1
(ja)
|
2013-06-06 |
2014-12-11 |
学校法人慶應義塾 |
NMO-IgGに拮抗する抗アクアポリン４抗体
|
|
EP3003390B1
(en)
|
2013-06-06 |
2021-07-07 |
Pierre Fabre Médicament |
Anti-c10orf54 antibodies and uses thereof
|
|
JP2016522249A
(ja)
|
2013-06-20 |
2016-07-28 |
ノバルティス アーゲー |
脈絡膜血管新生の治療におけるｖｅｇｆアンタゴニストの使用
|
|
US20160129080A1
(en)
|
2013-06-20 |
2016-05-12 |
Aaron Osborne |
Treatment of polypoidal chroidal vasculopathy
|
|
US20160130321A1
(en)
|
2013-06-20 |
2016-05-12 |
Gabriela Burian |
Use of a vegf antagonist in treating macular edema
|
|
CA2917402C
(en)
|
2013-07-09 |
2019-10-22 |
Hanwha Chemical Corporation |
Novel dual-targeting protein binding specifically to dll4 and vegf and use thereof
|
|
JP2016523956A
(ja)
|
2013-07-11 |
2016-08-12 |
ノバルティス アーゲー |
未熟児網膜症の治療におけるｖｅｇｆアンタゴニストの使用
|
|
BR112016000177A2
(pt)
|
2013-07-11 |
2017-12-12 |
Novartis Ag |
usos de um antagonista do vegf no tratamento de doenças neovasculares coriorretinianas e de permeabilidade em pacientes pediátricos, seringa pré-cheia, kit e formulação de liberação lenta
|
|
SI4374873T1
(sl)
|
2013-07-12 |
2026-01-30 |
Astellas Us Llc |
Sredstvo za uporabo pri zdravljenju ali preprečevanju oftalmoloških stanj
|
|
US9252430B2
(en)
|
2013-07-30 |
2016-02-02 |
Spectrum Brands, Inc. |
Alkaline cell with improved high rate capability
|
|
CN104341504B
(zh)
|
2013-08-06 |
2017-10-24 |
百奥泰生物科技(广州)有限公司 |
双特异性抗体
|
|
US20180221483A1
(en)
|
2013-08-16 |
2018-08-09 |
Board Of Trustees Of Northern Illinois University |
Timed release of substances to treat ocular disorders
|
|
US9962333B2
(en)
|
2013-08-16 |
2018-05-08 |
Board Of Trustees Of Northern Illinois University |
Timed release of substances to treat ocular disorders
|
|
US20150056195A1
(en)
|
2013-08-23 |
2015-02-26 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Compositions and methods for inihibiting tumorigenicity of senescent cancer cells induced by chemotherapy
|
|
US10617755B2
(en)
|
2013-08-30 |
2020-04-14 |
Genentech, Inc. |
Combination therapy for the treatment of glioblastoma
|
|
US10456470B2
(en)
|
2013-08-30 |
2019-10-29 |
Genentech, Inc. |
Diagnostic methods and compositions for treatment of glioblastoma
|
|
CN103421039B
(zh)
|
2013-09-03 |
2015-12-23 |
重庆工商大学 |
2-甲基丙烯酰氧基乙基磷酰胆碱的合成方法
|
|
ES2819217T3
(es)
|
2013-09-08 |
2021-04-15 |
Kodiak Sciences Inc |
Conjugados de polímeros iónicos dipolares y factor VIII
|
|
EP3043836B1
(en)
|
2013-09-11 |
2023-05-10 |
Neurotech USA, Inc. |
Encapsulated cell therapy cartridge
|
|
MX377714B
(es)
|
2013-10-18 |
2025-03-11 |
Regeneron Pharma |
Composiciones que comprenden una combinación de un antagonista de vegf y un anticuerpo anti-ctla-a.
|
|
WO2015058369A1
(en)
|
2013-10-23 |
2015-04-30 |
Sanofi (China) Investment Co., Ltd. |
Use of aflibercept and docetaxel for the treatment of nasopharyngeal carcinoma
|
|
CA2924520C
(en)
|
2013-11-01 |
2023-09-26 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease
|
|
ES2875878T3
(es)
|
2013-11-18 |
2021-11-11 |
Formycon Ag |
Composición farmacéutica de un anticuerpo anti-VEGF
|
|
US11104730B2
(en)
|
2013-11-20 |
2021-08-31 |
Regeneren Pharmaceuticals, Inc. |
Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors
|
|
US8883157B1
(en)
|
2013-12-17 |
2014-11-11 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
|
US9914769B2
(en)
|
2014-07-15 |
2018-03-13 |
Kymab Limited |
Precision medicine for cholesterol treatment
|
|
CN105611944A
(zh)
|
2013-12-20 |
2016-05-25 |
豪夫迈·罗氏有限公司 |
抗ang2抗体和cd40激动剂的组合疗法
|
|
JP2016530244A
(ja)
|
2013-12-31 |
2016-09-29 |
ディベロップメント センター フォー バイオテクノロジーＤｅｖｅｌｏｐｍｅｎｔ Ｃｅｎｔｅｒ Ｆｏｒ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ |
抗ｖｅｇｆ抗体及びその使用
|
|
WO2015101586A1
(en)
|
2014-01-03 |
2015-07-09 |
F. Hoffmann-La Roche Ag |
Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
|
|
US20170002060A1
(en)
|
2014-01-08 |
2017-01-05 |
Moderna Therapeutics, Inc. |
Polynucleotides for the in vivo production of antibodies
|
|
CN110981957B
(zh)
|
2014-01-15 |
2024-12-24 |
豪夫迈·罗氏有限公司 |
具有改善的蛋白A结合作用的Fc区变体
|
|
CN105026433B
(zh)
|
2014-01-24 |
2018-10-19 |
上海恒瑞医药有限公司 |
VEGF与PDGFRβ双特异性融合蛋白及其用途
|
|
JP6071099B1
(ja)
|
2014-01-25 |
2017-02-01 |
ツェンドゥー カンホン バイオテクノロジーズ カンパニー リミテッド |
血管の新生又は成長を抑制する融合タンパク質及びその用途
|
|
SG11201606714TA
(en)
|
2014-02-14 |
2016-09-29 |
Andrew S Chi |
Improved methods for the treatment of vascularizing cancers
|
|
EP3114138B1
(en)
|
2014-03-05 |
2021-11-17 |
Pfizer Inc. |
Improved muteins of clotting factor viii
|
|
WO2015135583A1
(en)
|
2014-03-12 |
2015-09-17 |
Universität Zu Köln |
Method for identifying a candidate subject for anti-vascular endothelial growth factor (vegf) therapy
|
|
KR101844596B1
(ko)
|
2014-03-18 |
2018-04-05 |
한국과학기술원 |
당화 vegf 디코이 수용체 융합 단백질을 포함하는 안질환 치료용 조성물
|
|
EP3122900A1
(en)
|
2014-03-24 |
2017-02-01 |
F. Hoffmann-La Roche AG |
Cancer treatment with c-met antagonists and correlation of the latter with hgf expression
|
|
PL3122878T3
(pl)
|
2014-03-24 |
2019-06-28 |
Translate Bio, Inc. |
TERAPIA mRNA DO LECZENIA CHORÓB OCZU
|
|
KR20160146747A
(ko)
|
2014-03-31 |
2016-12-21 |
제넨테크, 인크. |
항혈관신생제 및 ox40 결합 효능제를 포함하는 조합 요법
|
|
ES2719584T3
(es)
|
2014-04-11 |
2019-07-11 |
Medimmune Llc |
Compuestos conjugados que comprenden anticuerpos modificados por ingeniería genética con cisteína
|
|
WO2015168321A2
(en)
|
2014-04-29 |
2015-11-05 |
University Of Mississippi Medical Center |
Ocular compositions and methods thereof
|
|
US9388239B2
(en)
|
2014-05-01 |
2016-07-12 |
Consejo Nacional De Investigation Cientifica |
Anti-human VEGF antibodies with unusually strong binding affinity to human VEGF-A and cross reactivity to human VEGF-B
|
|
SG11201608868PA
(en)
|
2014-05-01 |
2016-11-29 |
Genentech Inc |
Anti-factor d antibody variants and uses thereof
|
|
WO2015168619A1
(en)
|
2014-05-02 |
2015-11-05 |
Mayo Foundation For Medical Education And Research |
Individualized treatment of eye disease
|
|
WO2015173260A1
(en)
|
2014-05-12 |
2015-11-19 |
Formycon Ag |
Pre-filled plastic syringe containing a vegf antagonist
|
|
EP3142664B1
(en)
|
2014-05-15 |
2019-12-04 |
Translatum Medicus Inc. |
Compositions and methods for treating and diagnosing ocular disorders
|
|
BR112016029864A2
(pt)
|
2014-06-17 |
2017-08-22 |
Clearside Biomedical Inc |
métodos e dispositivos para tratamento de desordens oculares posteriores.
|
|
US20170290876A1
(en)
|
2014-06-25 |
2017-10-12 |
Novartis Ag |
Compositions and methods for long acting proteins
|
|
US20170327553A1
(en)
|
2014-06-25 |
2017-11-16 |
Novartis Ag |
Compositions and methods for long acting proteins
|
|
WO2015200905A2
(en)
|
2014-06-28 |
2015-12-30 |
Oligasis, Llc |
Dual pdgf/vegf antagonists
|
|
JP2017523776A
(ja)
|
2014-07-14 |
2017-08-24 |
ジェネンテック， インコーポレイテッド |
膠芽腫の診断方法及びその治療用組成物
|
|
RS58957B1
(sr)
|
2014-07-18 |
2019-08-30 |
Sanofi Sa |
Postupak za predviđanje ishoda tretmana sa afliberceptom kod pacijenta za kog se sumnja da boluje od raka
|
|
EP3174897B1
(en)
|
2014-07-29 |
2020-02-12 |
F.Hoffmann-La Roche Ag |
Multispecific antibodies
|
|
WO2016025313A1
(en)
|
2014-08-11 |
2016-02-18 |
Samir Patel |
Methods for treating or preventing ophthalmological conditions
|
|
WO2016044041A1
(en)
|
2014-09-16 |
2016-03-24 |
Regeneron Pharmaceuticals, Inc. |
Predictive and prognostic biomarkers related to anti-angiogenic therapy of metastatic colorectal cancer
|
|
CN105435222B
(zh)
|
2014-09-25 |
2018-05-29 |
信达生物制药(苏州)有限公司 |
重组融合蛋白制剂
|
|
EP3207128B1
(en)
|
2014-10-17 |
2022-07-27 |
Kodiak Sciences Inc. |
Butyrylcholinesterase zwitterionic polymer conjugates
|
|
WO2016073157A1
(en)
|
2014-11-06 |
2016-05-12 |
Genentech, Inc. |
Anti-ang2 antibodies and methods of use thereof
|
|
WO2016073894A1
(en)
|
2014-11-07 |
2016-05-12 |
Eleven Biotherapeutics, Inc. |
Therapeutic agents with increased ocular retention
|
|
TWI806150B
(zh)
|
2014-11-07 |
2023-06-21 |
瑞士商諾華公司 |
穩定的含有高濃度抗vegf抗體之蛋白質溶液調配物
|
|
JP2017537896A
(ja)
|
2014-11-10 |
2017-12-21 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
二重特異性抗体及び眼科に使用する方法
|
|
US20160144025A1
(en)
|
2014-11-25 |
2016-05-26 |
Regeneron Pharmaceuticals, Inc. |
Methods and formulations for treating vascular eye diseases
|
|
CN106999511A
(zh)
|
2014-12-11 |
2017-08-01 |
拜耳医药保健有限责任公司 |
具有小的活动性脉络膜新生血管病变的年龄相关性黄斑变性的治疗
|
|
WO2016109943A1
(zh)
|
2015-01-06 |
2016-07-14 |
珠海亿胜生物制药有限公司 |
抗vegf抗体
|
|
TWI752901B
(zh)
|
2015-01-16 |
2022-01-21 |
日商中外製藥股份有限公司 |
合併用醫藥
|
|
SG11201705278QA
(en)
|
2015-01-28 |
2017-07-28 |
Pieris Pharmaceuticals Gmbh |
Novel proteins specific for angiogenesis
|
|
WO2016120753A1
(en)
|
2015-01-28 |
2016-08-04 |
Pfizer Inc. |
Stable aqueous anti- vascular endothelial growth factor (vegf) antibody formulation
|
|
EP3054007A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
|
|
TWI675844B
(zh)
|
2015-03-11 |
2019-11-01 |
新源生物科技股份有限公司 |
多靶向融合蛋白及其應用
|
|
US10421812B2
(en)
|
2015-03-31 |
2019-09-24 |
University Of Massachusetts |
Isoform specific soluble FMS-like tyrosine kinase (sFlt) binding agents and uses thereof
|
|
EP3278810A4
(en)
|
2015-03-31 |
2018-11-21 |
Ildong Pharm Co., Ltd. |
Pharmaceutical composition for preventing and treating eye diseases, containing, as active ingredient, fusion protein in which tissue-penetrating peptide and anti-vascular endothelial growth factor preparation are fused
|
|
AU2016243616A1
(en)
|
2015-03-31 |
2017-09-21 |
Janssen Biotech, Inc |
Antigen binding proteins
|
|
EP3286217A1
(en)
|
2015-04-23 |
2018-02-28 |
F. Hoffmann-La Roche AG |
Combination therapy of antibody binding to angiopoietin 2 with antibody binding to programmed death ligand 1
|
|
WO2016170039A1
(en)
|
2015-04-23 |
2016-10-27 |
F. Hoffmann-La Roche Ag |
Combination therapy of antibody binding to angiopoietin 2 with antibody binding to programmed death 1 polypeptide
|
|
US10202429B2
(en)
|
2015-06-08 |
2019-02-12 |
Retinal Solutions Llc |
Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema
|
|
US20180221339A1
(en)
|
2015-06-16 |
2018-08-09 |
Translatum Medicus, Inc. |
Compositions and methods for treating and diagnosing ocular disorders
|
|
MX2018000869A
(es)
|
2015-07-22 |
2018-07-06 |
Iconic Therapeutics Inc |
Metodos para tratar trastornos asociados con la angiogenesis y la neovascularizacion.
|
|
ES2913530T3
(es)
|
2015-08-12 |
2022-06-02 |
Novartis Ag |
Métodos para tratar trastornos oftálmicos
|
|
CN107849122B
(zh)
|
2015-08-21 |
2022-01-25 |
豪夫迈·罗氏有限公司 |
用低电导率洗涤缓冲液进行亲和层析纯化
|
|
AU2016317882B2
(en)
|
2015-09-01 |
2021-01-28 |
Ildong Pharmaceutical Co., Ltd. |
Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseases
|
|
WO2017046140A1
(en)
|
2015-09-18 |
2017-03-23 |
Bayer Pharma Aktiengesellschaft |
Treatment regimens for dr and rvo in dependence of the extent of retinal ischemia
|
|
JP6959912B2
(ja)
|
2015-09-23 |
2021-11-05 |
ジェネンテック， インコーポレイテッド |
抗ｖｅｇｆ抗体の最適化変異体
|
|
CN108290958B
(zh)
|
2015-10-02 |
2021-12-28 |
豪夫迈·罗氏有限公司 |
多特异性抗体
|
|
JP7725185B2
(ja)
|
2015-10-06 |
2025-08-19 |
アレクトル エルエルシー |
抗ｔｒｅｍ２抗体及びその使用方法
|
|
US20170114127A1
(en)
|
2015-10-22 |
2017-04-27 |
Massachusetts Institute Of Technology |
Vegf-a-binding proteins and her2-binding proteins with enhanced stability against aggregation
|
|
TW201730211A
(zh)
|
2015-10-30 |
2017-09-01 |
建南德克公司 |
抗因子d抗體及結合物
|
|
ES2815224T3
(es)
|
2015-11-06 |
2021-03-29 |
Promise Proteomics |
Un método para cuantificar anticuerpos terapéuticos
|
|
WO2017083791A1
(en)
|
2015-11-13 |
2017-05-18 |
Iconic Therapeutics, Inc. |
Methods and compositions for treating disorders associated with pathological neovascularization
|
|
US20180326126A1
(en)
|
2015-11-18 |
2018-11-15 |
Formycon Ag |
Pre-filled plastic syringe containing a vegf antagonist
|
|
CN108883172A
(zh)
|
2015-11-18 |
2018-11-23 |
福迈康股份公司 |
包含vegf拮抗剂的液体配制品的预填充药物包装
|
|
US10703810B2
(en)
|
2015-11-30 |
2020-07-07 |
Pieris Australia Pty Ltd. |
Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)
|
|
KR20210157427A
(ko)
|
2015-12-03 |
2021-12-28 |
리제너론 파마슈티칼스 인코포레이티드 |
항-vegf로 치료된 연령-관련 황반 변성을 앓고 있는 환자에서의 임상 결과와 유전적 변이체를 연관시키는 방법
|
|
KR102944785B1
(ko)
*
|
2015-12-09 |
2026-03-30 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
안구 질환 또는 장애의 치료 방법
|
|
CA3010329A1
(en)
|
2015-12-29 |
2017-07-06 |
Oncobiologics, Inc. |
Buffered formulations of bevacizumab
|
|
IL290457B2
(en)
|
2015-12-30 |
2025-02-01 |
Kodiak Sciences Inc |
Antibodies and their conjugates
|
|
EP3401331B1
(en)
|
2016-01-06 |
2022-04-06 |
Order-Made Medical Research Inc. |
High-affinity anti-vegf antibody
|
|
WO2017119434A1
(ja)
|
2016-01-06 |
2017-07-13 |
株式会社オーダーメードメディカルリサーチ |
Ｖｅｇｆとｎｒｐ１との結合を阻害する抗体
|
|
CN108778330A
(zh)
|
2016-01-08 |
2018-11-09 |
科尼尔赛德生物医学公司 |
用阿柏西普和其他生物制品治疗后眼部障碍的方法和装置
|
|
WO2017120600A1
(en)
|
2016-01-08 |
2017-07-13 |
Clearside Biomedical, Inc. |
Compositions and methods of treating wet age-related macular degeneration
|
|
CN107043422B
(zh)
|
2016-01-28 |
2022-01-04 |
成都康弘生物科技有限公司 |
抗补体因子D的人源化Fab和人源化抗体及其用途
|
|
JP7014724B2
(ja)
|
2016-02-06 |
2022-02-01 |
エピムアブ バイオセラピューティクス インコーポレイテッド |
タンデム型Ｆａｂ免疫グロブリンおよびその使用
|
|
US20170224815A1
(en)
|
2016-02-09 |
2017-08-10 |
Nima Tirgan |
Method of Preventing and Treating Retinal Microvasculature Inflammation Using C-Met Signaling Pathway Inhibition
|
|
EP3211422A1
(en)
|
2016-02-23 |
2017-08-30 |
Justus-Liebig-Universität Gießen |
Method for measurement and control of intraocular vegf concentration
|
|
CN109069638B
(zh)
|
2016-03-24 |
2022-03-29 |
璟尚生物制药公司 |
用于癌症治疗的三特异性抑制剂
|
|
JP6600405B2
(ja)
|
2016-04-07 |
2019-10-30 |
インダストリー−ユニバーシティー コーペレイション ファンデーション ハンヤン ユニバーシティー エリカ キャンパス |
新血管生成抑制のための血管内皮成長因子受容体ターゲッティングペプチド−エラスチン融合ポリペプチド及び自己組立ナノ構造体
|
|
JP6938536B2
(ja)
|
2016-04-14 |
2021-09-22 |
アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ |
新規のｖｅｇｆｒ２コレセプターであるｓｃｕｂｅ２の阻害による、腫瘍血管新生の抑制
|
|
EP3442554A4
(en)
|
2016-04-14 |
2019-12-04 |
Iconic Therapeutics, Inc. |
COMPOSITIONS AND METHODS OF TREATING DISEASES RELATED TO NEOVASCULARIZATION
|
|
JP2019515027A
(ja)
|
2016-04-15 |
2019-06-06 |
レジェンクスバイオ インコーポレーテッド |
翻訳後修飾された完全ヒト抗ＶＥＧＦ Ｆａｂを用いる眼疾患の治療
|
|
IL262207B2
(en)
|
2016-04-15 |
2026-01-01 |
Univ Pennsylvania |
Preparations for the treatment of wet age-related macular degeneration
|
|
ES2908467T3
(es)
|
2016-04-29 |
2022-04-29 |
Adverum Biotechnologies Inc |
Evasión de anticuerpos neutralizantes por un virus adenoasociado recombinante
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
CN109310756B
(zh)
|
2016-05-13 |
2022-06-28 |
奥美药业有限公司 |
新型血管生成素2，vegf双特异性拮抗剂
|
|
CN109563479A
(zh)
|
2016-05-25 |
2019-04-02 |
约翰霍普金斯大学 |
作为新型生物制剂递送平台的工程化的无核细胞和细胞外囊泡
|
|
EP3463349B1
(en)
|
2016-05-25 |
2021-08-04 |
Santen Pharmaceutical Co., Ltd. |
Use of sirolimus to treat exudative age-related macular degeneration with persistent edema
|
|
PL3472317T3
(pl)
|
2016-06-16 |
2022-08-08 |
Adverum Biotechnologies, Inc. |
Kompozycje i sposoby zmniejszania neowaskularyzacji oka
|
|
CA3026518A1
(en)
|
2016-06-17 |
2017-12-21 |
Genentech, Inc. |
Purification of multispecific antibodies
|
|
CN109689102A
(zh)
|
2016-08-12 |
2019-04-26 |
基因泰克公司 |
Mek抑制剂,pd-1轴抑制剂,和vegf抑制剂的组合疗法
|
|
JP7186400B2
(ja)
|
2016-08-30 |
2022-12-09 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ゲノム的に再コードした生物におけるセレノ－生物製剤の製造
|
|
US11254738B2
(en)
|
2016-09-07 |
2022-02-22 |
The Governing Council Of The University Of Toronto Banting Institute |
Synthetic antibodies against VEGF and their uses
|
|
EP3515536A1
(en)
|
2016-09-19 |
2019-07-31 |
Lupin Limited |
In-line filter for protein/peptide drug administration
|
|
WO2018070390A1
(ja)
|
2016-10-12 |
2018-04-19 |
第一三共株式会社 |
抗ｒｏｂｏ４抗体と他剤を含む組成物
|
|
US11801307B2
(en)
|
2016-10-14 |
2023-10-31 |
University Of Utah Research Foundation |
Antibody-polymer-drug conjugates
|
|
EP3532498A1
(en)
|
2016-10-31 |
2019-09-04 |
Hexal AG |
Antibody preparation
|
|
US11123411B2
(en)
|
2016-12-08 |
2021-09-21 |
Gary E. Borodic |
Method of treating macular degeneration using botulinum toxin-based pharmaceuticals
|
|
WO2018114728A1
(en)
|
2016-12-20 |
2018-06-28 |
F. Hoffmann-La Roche Ag |
Combination therapy with a bispecific anti-ang2/vegf antibody and a bispecific anti-her2 antibody
|
|
WO2018122053A1
(en)
|
2016-12-29 |
2018-07-05 |
F. Hoffmann-La Roche Ag |
Anti-angiopoietin-2 antibody formulation
|
|
US20190358335A1
(en)
|
2017-01-12 |
2019-11-28 |
Alan J. Russell |
Stomach acid-stable and mucin-binding protein-polymer conjugates
|
|
CN110545836A
(zh)
|
2017-01-24 |
2019-12-06 |
马克雷根有限公司 |
用载脂蛋白模拟物治疗与年龄有关的黄斑变性和其他眼部疾病
|
|
EP3573641A4
(en)
|
2017-01-25 |
2020-11-11 |
Iconic Therapeutics, Inc. |
TREATMENT METHODS FOR DISORDERS ASSOCIATED WITH ANGIOGENESIS AND NEOVASCULARIZATION
|
|
KR102252450B1
(ko)
|
2017-02-09 |
2021-05-14 |
주식회사 아미코젠파마 |
우르소데옥시콜산을 함유하는 시각장애 예방 또는 치료용 조성물
|
|
TW201840584A
(zh)
|
2017-03-20 |
2018-11-16 |
美商歐樂根公司 |
針對vegf之僅含重鏈之抗體
|
|
EP3600442A1
(en)
|
2017-03-22 |
2020-02-05 |
Genentech, Inc. |
Optimized antibody compositions for treatment of ocular disorders
|
|
JP7216006B2
(ja)
|
2017-03-22 |
2023-01-31 |
ジェネンテック， インコーポレイテッド |
ヒドロゲル架橋ヒアルロン酸プロドラッグ組成物及び方法
|
|
WO2018182527A1
(en)
|
2017-03-30 |
2018-10-04 |
National University Of Singapore |
Method for treating inflammatory complications in eye diseases
|
|
WO2018185110A1
(en)
|
2017-04-03 |
2018-10-11 |
Fit Biotech Oy |
Novel expression vectors and uses thereof
|
|
CN106905431B
(zh)
|
2017-04-10 |
2020-01-17 |
旭华（上海）生物研发中心有限公司 |
抗人补体d因子的单克隆抗体及其用途
|
|
CA3059938A1
(en)
|
2017-04-14 |
2018-10-18 |
Kodiak Sciences Inc. |
Complement factor d antagonist antibodies and conjugates thereof
|
|
WO2018217995A1
(en)
|
2017-05-24 |
2018-11-29 |
Formycon Ag |
Sterilizable pre-filled pharmaceutical packages comprising a liquid formulation of a vegf-antagonist
|
|
US20200140547A1
(en)
|
2017-05-26 |
2020-05-07 |
The Johns Hopkins University |
Multifunctional antibody-ligand traps to modulate immune tolerance
|
|
US10460482B2
(en)
|
2017-07-26 |
2019-10-29 |
Robert Bosch Gmbh |
Method and system for automated generation of constrained curves in computer graphics
|
|
WO2019020777A1
(en)
|
2017-07-26 |
2019-01-31 |
Formycon Ag |
LIQUID FORMULATION OF A VEGF ANTAGONIST
|
|
WO2019040397A1
(en)
|
2017-08-21 |
2019-02-28 |
Ophthotech Corporation |
METHOD FOR TREATING OR PREVENTING MACULAR DEGENERATION OF THE NEOVASCULAR AGE
|
|
GB201713724D0
(en)
|
2017-08-25 |
2017-10-11 |
Ucl Business Plc |
Formulation
|
|
JP2020532586A
(ja)
|
2017-08-31 |
2020-11-12 |
シンガポール ヘルス サービシーズ プライベート リミテッド |
網膜血管性疾患の処置のためのａｎｇｉｏ−３
|
|
EP3457139B1
(en)
|
2017-09-19 |
2026-08-05 |
Promise Proteomics |
Antibody-like peptides for quantifying therapeutic antibodies
|
|
CN107602702A
(zh)
|
2017-09-22 |
2018-01-19 |
生标（上海）医疗器械科技有限公司 |
一种同时靶向人p185和血管内皮生长因子的抗体及其应用
|
|
WO2019057946A1
(en)
|
2017-09-25 |
2019-03-28 |
F. Hoffmann-La Roche Ag |
MULTI-CYCLIC AROMATIC COMPOUNDS AS D-FACTOR INHIBITORS
|
|
CA3076905A1
(en)
|
2017-09-27 |
2019-04-04 |
The Johns Hopkins University |
Treatment of ocular diseases with fully-human post-translationally modified anti-vegf fab
|
|
US12564632B2
(en)
|
2017-11-08 |
2026-03-03 |
Yafei Shanghai Biolog Medicine Science & Technology Co., Ltd. |
Conjugates of biomolecule and use thereof
|
|
AU2018370135A1
(en)
|
2017-11-16 |
2020-06-04 |
Iveric Bio, Inc. |
A method for treating or preventing idiopathic polypoidal choroidal vasculopathy (IPCV)
|
|
US11766489B2
(en)
|
2017-11-27 |
2023-09-26 |
4D Molecular Therapeutics, Inc. |
Adeno-associated virus variant capsids and use for inhibiting angiogenesis
|
|
JP2021507723A
(ja)
|
2017-12-05 |
2021-02-25 |
ユニバーシティ オブ ワシントンＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｗａｓｈｉｎｇｔｏｎ |
視細胞における治療遺伝子の機能的発現を増強するための組成物および方法
|
|
CN110283248B
(zh)
|
2018-01-05 |
2020-07-28 |
百奥泰生物制药股份有限公司 |
一种长效低毒的重组抗vegf人源化单克隆抗体及其生产方法
|
|
US11524053B2
(en)
|
2018-01-26 |
2022-12-13 |
The Regents Of The University Of California |
Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents
|
|
CN111699004A
(zh)
|
2018-02-06 |
2020-09-22 |
豪夫迈·罗氏有限公司 |
眼科疾病的治疗
|
|
US11827697B2
(en)
|
2018-02-11 |
2023-11-28 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
Anti-PD-1/anti-VEGF natural antibody structure like heterodimeric form bispecific antibody and preparation thereof
|
|
WO2019164219A1
(en)
|
2018-02-20 |
2019-08-29 |
Institute For Basic Science |
Anti-angiopoietin-2 antibodies and uses thereof
|
|
CA3092588A1
(en)
|
2018-03-02 |
2019-09-06 |
Kodiak Sciences Inc. |
Il-6 antibodies and fusion constructs and conjugates thereof
|
|
WO2019173482A1
(en)
|
2018-03-06 |
2019-09-12 |
Sanford Burnham Prebys Medical Discovery Institute |
4-aminoquinoline compounds for the treatment of angiogenesis
|
|
TW202003553A
(zh)
|
2018-03-15 |
2020-01-16 |
美商艾伯維有限公司 |
用於治療癌症之abbv-621與抗癌劑之組合
|
|
MX2020009140A
(es)
|
2018-03-16 |
2020-09-28 |
Novartis Ag |
Metodos para el tratamiento de enfermedades oculares.
|
|
WO2019184909A1
(zh)
|
2018-03-27 |
2019-10-03 |
信达生物制药(苏州)有限公司 |
新型抗体分子、其制备方法及其用途
|
|
WO2019195313A1
(en)
|
2018-04-04 |
2019-10-10 |
Pollack Aryeh L |
Anti-vegf antagonist and pedf agonist constructs and uses thereof
|
|
US20190307691A1
(en)
|
2018-04-05 |
2019-10-10 |
Northern Illinois Research Foundation |
Hydrogels with liposomes for controlled release of drugs
|
|
KR20210009315A
(ko)
|
2018-04-11 |
2021-01-26 |
오하이오 스테이트 이노베이션 파운데이션 |
안약 전달용 서방형 마이크로 입자를 이용한 방법 및 조성물
|
|
WO2019201866A1
(en)
|
2018-04-16 |
2019-10-24 |
Swedish Orphan Biovitrum Ab (Publ) |
Fusion protein
|
|
AU2019256289A1
(en)
|
2018-04-17 |
2020-11-12 |
Outlook Therapeutics, Inc. |
Buffered formulations of bevacizumab for use of treating diseases
|
|
RS67656B1
(sr)
|
2018-05-10 |
2026-02-27 |
Regeneron Pharma |
Formulacije koje sadrže visoke koncentracije fuzionog proteina vegf receptora
|
|
US11519020B2
(en)
|
2018-05-25 |
2022-12-06 |
Regeneron Pharmaceuticals, Inc. |
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
|
|
WO2019229116A1
(en)
|
2018-05-31 |
2019-12-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Intravitreal delivery of a decorin polypeptide for the treatment of choroidal neovascularisation
|
|
JP2021529557A
(ja)
|
2018-06-29 |
2021-11-04 |
ジェンサン バイオファーマ、 インコーポレイテッドＧｅｎｓｕｎ Ｂｉｏｐｈａｒｍａ， Ｉｎｃ． |
抗腫瘍免疫チェックポイント調節因子アンタゴニスト
|
|
WO2020006486A1
(en)
|
2018-06-29 |
2020-01-02 |
Krystal Biotech, Inc. |
Compositions and methods for antibody delivery
|
|
WO2020023841A1
(en)
|
2018-07-27 |
2020-01-30 |
Massachusetts Institute Of Technology |
Oligomerized protein-polymer conjugates
|
|
JP2021534188A
(ja)
|
2018-08-17 |
2021-12-09 |
メルサナ セラピューティクス インコーポレイテッド |
ＮａＰｉ２ｂに標的指向されたポリマー抗体−薬物コンジュゲートおよびその使用方法
|
|
JP7249060B2
(ja)
|
2018-08-17 |
2023-03-30 |
トリカン・バイオテクノロジー・カンパニー・リミテッド |
抗血管新生融合タンパク質およびその使用
|
|
CN109053895B
(zh)
|
2018-08-30 |
2020-06-09 |
中山康方生物医药有限公司 |
抗pd-1-抗vegfa的双功能抗体、其药物组合物及其用途
|
|
EP3856245A4
(en)
|
2018-09-24 |
2022-10-26 |
EyePoint Pharmaceuticals, Inc. |
MULTISPECIFIC ANTIBODIES AGAINST HPTP - BETA (VE-PTP) AND VEGF
|
|
US12109273B2
(en)
|
2019-02-15 |
2024-10-08 |
Wuxi Xdc Singapore Private Limited |
Process for preparing antibody-drug conjugates with improved homogeneity
|
|
CA3157509A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
US20210254073A1
(en)
|
2020-02-04 |
2021-08-19 |
Cornell University |
Methods for capture and analysis of macromolecular complexes
|
|
WO2021226404A1
(en)
|
2020-05-08 |
2021-11-11 |
Kodiak Sciences Inc. |
Use of il-6 antibodies and vegf traps, and fusion constructs and conjugates thereof
|
|
EP4323399A4
(en)
|
2021-04-14 |
2025-04-09 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
US20230250133A1
(en)
|
2022-02-10 |
2023-08-10 |
Kodiak Sciences Inc. |
Methods of purifying a product
|
|
AU2024286366A1
(en)
|
2023-06-07 |
2025-12-04 |
Kodiak Sciences Inc. |
Compositions of conjugated and unconjugated proteins
|